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INTRODUCTION 
In the late 1950's and early 1960's Myers and co­
workers at the Squibb Institute for Medical Research, 
extracted a substance from the cancellous bone of growing 
young mammals. This substance when applied to the 
periosteal surface of adult rat bones caused a rapid, 
massive growth of periosteal new bone. Some of the treated 
bones doubled their diameter in just seven days. 
E. R. Squibb B Sons* chose not to pursue research on 
the substance. Some years later, Tornberg and Bassett 
(1977) obtained some samples of this substance for their 
experiments. They characterized some of the effects this 
substance had on the cells of the periosteum, and they 
hypothesized what the active agent is and how it works. 
They showed that the substance activates the resting 
cells of the cambium layer of the periosteum. In just 72 
hours, these cells reproduced themselves to form palisades 
of active osteoblastic cells. Within seven days, the 
original bone was covered with a sleeve of cancellous bone 
that doubled its diameter. 
This substance, derived from the cancellous bone of 
growing mammals, will be referred to as periosteal 
1 E. R. Squibb 6 Sons, Inc., The Squibb Institute for 
Medical Research, P. 0. Box UOOO, Princeton, N. J. 
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activation agent (PAA). The primary objective of this 
research is to characterize the effects that this periosteal 
activation agent has on bone repair and bone ingrowth into a 
porous biocompatible implant. This study will investigate 
the feasibility of using PAA at the non-human level to 
encourage bone ingrowth into biocompatible porous implants, 
to aid healing, and in general, to characterize some of the 
effects of PAA on hone, medullary, endosteal, and periosteal 
tissues. It will examine how PAA alters the forms, types, 
volumes, and time sequence of these tissues. Radioactive 
tracers, light microscope, photographic, and computer 
techniques will be utilized to measure the amounts of new 
bone formation. Research into the chemical composition of 
PAA and how it biochemically influences cells is beyond the 
scope of this disquisition. 
A specific bone activation substance, if it can be 
isolated, may lead to many therapeutic applications, 
including some that may not now be directly foreseen. It 
may find uses as an agent to stimulate bone ingrowth into 
porous implant materials. Biocompatible porous materials 
have been shown to be adequate interfacial materials for 
making contact between artificial hip replacements and 
living bone (Lord et al. 1979; Judet et al. 1978; Boutin, 
1977). The bone grows into the interstices of the implant, 
and forms a solid bond between bone and prosthesis that 
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eliminates the need for methyl methacrylate cement and the 
deleterious effects that are associated with it (Judet et 
al. 1978; Holm, 1980). The main disadvantage of such 
implants is that a method must be implemented to immobilize 
the bone-implant complex until the bone ingrowth process is 
sufficiently advanced to adequately bind the bone to the 
prosthesis under the stresses applied by the patients normal 
activity. Use of a substance that would accelerate bone 
ingrowth may greatly increase the success rate of these 
prostheses. 
Something that causes a rapid bone growth at the 
periosteum may be used to promote the reattachment of 
tendons and ligaments to bone, or the attachment of 
artificial ligaments to bone. Large purebred steers often 
suffer injuries to their stifle joints. Repair of the 
stifle joint can involve reattachment of the crucial 
ligament, or attachment of an artificial crucial ligament. 
In humans suffering from rheumatoid arthritis, the tibial 
collateral ligaments are often injured. Research is 
currently underway to develop artificial ligaments for these 
people. The main research problem would involve the 
attachment of the artificial ligament to the bone. A 
periosteal activation substance may lead to a breakthrough 
in this area of research. 
Although a bone activation substance may not be needed 
u 
for normal fracture repair, it may be able to promote 
fracture healing in those cases where it is slow or non­
existent. Normal healthy mammalian bone has a great ability 
to repair itself; in some human cases, gaps of up to six 
inches have been bridged (Hartshorne, 1841). But in some 
patients, age, disease, or unknown factors may hinder 
healing, sometimes creating a permanent false joint or 
pseudarthrosis. Such a substance might be used to initiate 
the normal bone healing process in such individuals. 
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LITEP.ATDRE REVIEW 
The following sections will discuss bone, bone 
formation, bone induction, and previous work on activation 
of the resting periosteum, and will briefly describe 
morphogens and bioelectricity. A study of some previous 
work done on bone formation, bone induction, and periosteal 
activation helps to put this research in perspective and to 
provide a historical background, florphogens and 
bioelectricity may be involved in the mechanism of 
periosteal activation. 
It is important to understand the differences between 
bone induction and activation of the resting periosteum. 
Bone induction is the process where cells in a host organism 
are induced to form new bone by some substance, matrix, or 
tissue with which they are placed in contact, it is often 
used to refer to bone formation in tissues that normally do 
not form bone, such as the inner chamber of the eye or mus­
cle tissue, but it can refer to stimulation of bone growth 
in normal skeletal tissue. Activation of the resting peri­
osteum differs from this in that bone growth occurs exclu­
sively in the cambium layer of the periosteum. There is no 
bone growth seen in outlying tissues. Also, the rate of 
growth is different in activation of the resting periosteum 
than in classic bone induction. In the classic bone induc­
tion studies, bone growth requires about 7 to 11 days to get 
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started. With activation of the resting periosteum, bone 
growth is completed in seven days. In some cases, the 
amount of bone produced by activation of the periosteum can 
be phenomenal. The diameter of the radius and ulna bones in 
rats may double in just seven days (Tornberg and Bassett, 
1977). Although activation of the resting periosteum may 
perhaps be viewed as a form of bone induction, its 
difference from other forms of induction should be 
recognized. 
Bone 
Bone is one of several types of mineralized tissue that 
can occur in the animal body. These mineralized tissues 
include calcified cartilage, calcified tendon, and dental 
materials. They are all composed of three major elements: 
collagen fibers, inorganic materials, and an organic ground 
substance. In addition, most mineralized tissues contain 
cells. These tissues differ from each other by their 
proportion of fibers, minerals, and ground substance; by the 
types and arrangements of their collagen fibers; and by the 
types, densities and arrangement of their cells. 
In bone, the collagen fibers are UO nm to 120 nm in 
diameter, and they account for about one third the dry 
weight of bone. They are similar, but not identical to 
collagen elsewhere in the body. 
Most of the remaining two thirds of the bone mass is 
provided by the bone mineral. The bone mineral has been 
described as a paracrystal similar to hydroxyapatite, 
CajQ (P04)g (OH)2• The paracrystals occur as either needle 
shaped or tubular shaped objects about 3 to 5 nm wide and 60 
nm long. They are closely associated with the collagen 
fibers, many of them occurring inside the fibers. The 
paracrystals are not exactly hydroxyapatite because they 
contain trace amount of other ions and anions and because 
their calcium-phosphate ratio is seldom exactly 1.67. They 
are called paracrystals because X-ray diffraction studies 
(Wheeler and lewis, 1977) show that the distances between 
their atoms vary slightly. A paracrystal is a substance 
that is midway between an amorphous material and a regular 
crystalline array. 
The third component of bone is often referred to as 
cement or as ground substance. It is actually not a single 
entity, but a broad grouping of all the non-collagenous, 
organic substances that comprise bone. The components 
include glycosaminoglycans, condroitin sulfates A and B, 
sialoprotein, CP-S glycoprotein, lipids, peptides, and other 
glycoproteins and proteins. These substances nay assist in 
the nucleation of bone mineral, and they may aid in the 
transport of nutrients to the bone cells. 
The three main cells associated with bone are 
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osteocytes, osteoblasts, and osteoclasts. Osteoclasts are 
large multinucleated cells formed from fused monocytes. 
They remove bone. They digest the collagen and the ground 
substance of bone as well as the bone mineral. Osteoblasts 
are cells that produce bone. They can lay down the fibers, 
ground substance, and bone mineral. When an osteoblast 
becomes trapped in its own matrix, it is called an 
osteocyte. Osteocytes may play a role in maintaining or 
removing some bone and in mineral homeostasis. 
The formation of bone is generally classified into one 
of two types, intramembranous ossification and endochondral 
ossification. Intramembranous ossification refers to the 
mineralization of any membranous tissue. Endochondral 
ossification is the replacement of cartilage with bone. 
In endochondral ossification, the cartilage cells, 
called chondrocytes, pass through several stages before they 
are replaced by bone. First, the chondrocytes tend to 
arrange themselves in long parallel lines called palisades. 
The chondrocytes in the palisades then begin to mineralize. 
As the chondrocytes become mineralized, they lose the 
ability to absorb nutrients. They then hypertrophy and die. 
The mineralized cell spaces or lacunae of the dead 
chondrocytes are then invaded by blood vessels and 
osteoblasts. The osteoblasts deposit a new bone matrix to 
form a course cancellous bone. When endochondral 
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ossification is occurring, usually a series of these stages 
of ossification is present. There is a zone of palisading 
osteocytes, a zone of osteocyte mineralization and 
hypertrophy, and a zone of vascular invasion. 
Bone can be classified by either its elementary 
organization or by its higher organization. Classification 
according to its elementary organization is based on whether 
or not the fibers occur in coarse or fine bundles and 
whether or not they occur in a woven, parallel, or lamellar 
pattern. However, in most histological preparations the 
fibers can not be seen. For this reason, a simplified 
system that classifies bone into three types is usually 
used. The three types are bundle bone, woven bone, and 
fine-fibered bone. 
Bundle bone is bone that contains coarse fiber bundles 
with osteocytes that follow the pattern of the bundles. It 
is found in the lower skeleton of vertebrates, at 
attachments of tendon and ligaments, in some fish scales, 
and in ossified tendons of birds. 
Woven bone is composed of coarse loosely packed fibers, 
varying in size up to 30 nm in diameter, arranged in an 
irregular overlapping pattern. It has large, randomly 
dispersed osteocytes. In hematoxylin and eosin, it stains 
bluish or purplish due to its basophilic content. It occurs 
in fish scales, the flat dermal bones of amphibians and 
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snakes, in the fetal skeleton of mammals, and in the early 
fracture callus. 
Fine-fibered bone includes both parallel and lamellar 
bone. Much of this classification of bone is lamellated, 
and polarized light will reveal the lamallae. This type of 
bone has a clear eosinophilic matrix with small ovoid 
osteocytes at regular, wide intervals. This is the 
predominant type of bone found in adult mammals, in some 
extinct reptiles such as dinosaurs and pterosaurs, and in 
the long bones of birds. 
In mammals, bundle and woven bone are mostly temporary 
structures found in the growing animal, to be gradually 
replaced by fine-fibered bone. However, there are some 
sites in the mammalian skeleton where these types of bone 
will remain throughout adult life. Woven bone is 
characteristic of rapid bone growth. It usually possesses a 
rich vascular supply. Bundle bone generally developes in a 
more orderly manner from tendon and ligament cells that 
transform into osteoblasts and osteocytes and develope a 
mineral matrix. Fine-fibered bone is often formed by the 
gradual remodelling of bundle and woven bone and by surface 
apposition. It usually has a single layer of osteoblasts at 
its surface. 
Bone is usually classified into two or three types with 
respect to its higher organization. Actually these 
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classification systems are an oversimplification. What is 
typically classified as compact bone can be identified as 
over a dozen distinct types of bone. The traditional 
classifications of bone are coarse cancellous, fine 
cancellous, and compact bone. 
Coarse cancellous bone is the spongy bone found in the 
medullary canal and formed by deposition of new bone from 
the endosteal surface. It is comprised of coarse trabeculae 
of bone arranged in a haphazard, irregular pattern. It may 
have a lamellar or non-lamellar matrix. 
Fine cancellous bone is more dense and compact than 
coarse cancellous bone, but not as solid as compact bone. 
It is found in the fetal skeleton, at secondary centers of 
ossification, in the early fracture callus, and, in general, 
at any site where bone growth is rapid. 
The compact varieties of bone are more dense and 
compact than the cancellous varieties of bone. They can be 
formed by: (1) consolidation of fine and coarse cancellous 
bone, (2) direct apposition on periosteal and endosteal 
surfaces, and (3) remodelling of existing forms of compact 
bone with the formation of secondary osteons. 
Compacted coarse-cancellous bone is formed when coarse 
cancellous bone is converted into compact bone. The old 
trabeculae of the coarse cancellous bone are filled with 
primary osteons and lamellae that follow the convolutions of 
12  
the original trabeculae, leaving a convoluted, whorled 
arrangement in the new formed cortical area. 
Compacted fine-cancellous bone occurs when the fine 
cancellous bone is compacted. 
Inner circumferential lamallae bone is formed by 
endosteal growth in areas of the diaphysis where there are 
few cancellous trabeculae. Outer circumferential lamellae 
are formed by periosteal apposition onto preexisting 
cortical bone. They are characterized by concentric 
lamellae that conform to the general contour of the bone. 
Many types of compact bone are classified by their type 
of canal or vascular supply system. In man and other 
primates, there are many areas of non-vascular bone that are 
completely lacking a canal system. 
Primary vascular bone has primary canals but no 
osteons. These primary canals are not surrounded by rings 
of lamellae as the osteons are, and they tend to run in a 
mostly longitudinal direction. Primary vascular bone is the 
most common type of bone in most vertebrate groups, and it 
is the chief type of bone in man during the active growth 
period following birth. 
Primary osteons form an anastomosing network that fill 
some spaces when cancellous bone is compacted. They are 
usually smaller then secondary osteons, being just two or 
three circumferential lamellae rings around two or more 
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blood vessels. They are formed by the periosteum in the 
postnatal skeleton and sometimes by the endosteum. They are 
common in the fast growing animal and often occur in rows or 
layers. 
The secondary osteon is often incorrectly described as 
forming the basic unit of compact bone. It does not. It 
occurs only in areas that have been remodelled. In the 
formation of a secondary osteon, osteoclasts first form a 
resorption cavity, usually larger than 100 yum in diameter. 
Osteoblasts then enter the cavity and start laying down 
concentric layers of bone. After each lamella is formed, a 
circular layer of osteoblasts become trapped in the margin 
between each lamella. These osteoblasts become osteocytes 
that act to maintain the bone matrix and to interact in 
mineral homeostasis. Extending outward from each osteocyte 
trapped in its space, or lacuna, are many tiny canals or 
caniculi that connect each osteocyte to adjacent osteocytes 
in the same osteon. The caniculi contain cell processes 
that connect the osteocytes. When the secondary osteon is 
complete, there is a single capillary in the center 
surrounded by a "tree ring" formation of lamellae. The 
outer border of the osteon will be a cement line which marks 
the limit of the old resorption cavity. 
The compact bone in rabbit femurs, as are used in this 
study, included compacted fine-cancellous, compacted coarse-
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cancellous, outer circumferential lamellae, inner 
circumferential lamellae, and a few areas of primary 
vascular bone. Primary osteons are common, but secondary 
osteons are usually only seen at sites of bone repair where 
necrotic bone near an injury site has been remodelled to 
secondary haversion bone. The new bone elicited by PAA is 
fine cancellous bone. This fine cancellous bone is expected 
to be either resorbed or converted to compacted fine-
cancellous bone. 
Bone Formation 
Fell (1928, 1932a, 1932b) and Bassett (1962) did a 
series of experiments on the osteogenic capacity of bone 
cells in vitro. Their experiments will be examined in some 
detail because they define the basic forces that result in 
the formation of bone. They outline the different paths 
that bone precursor tissue can take when it differentiates, 
and identify the forces that cause these departures. As 
shown in Figure 1, an expiant of bone was placed in a plasma 
clot on a cover slip. After a few days, an outgrowth of 
connective tissue elements and some capillaries emerged 
around the perimeter of the expiant. At six days, the 
original piece of bone was excised from the clot. The 
remaining clot with its tissue outgrowth contracted, and the 
growing tissue gradually filled the center. After 11 days. 
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the clot appeared as shown in Figure 2. An outer shell of 
bone was formed in the area that was in direct contact with 
the high oxygen atmosphere. Underneath that was a 
cartilaginous core. During the process, the clot surface 
gradually progressed from material that resembled embryonic 
cartilage to hyaline cartilage to fibrocartilage, and 
finally to bone. 
This experiment was repeated and altered by Bassett 
(1962). Bassett used expiants from bone, skeletal muscle, 
and tendon. Two types of cells were characterized in the 
outgrowth around the expiant. Originally, amoeboid, 
spindle-shaped cells were seen embedded in the fibrin 
network of the clot. These cells gradually changed their 
outline to become more spherical when the expiant was 
removed and the clot contracted. These spindle-shaped cells 
accounted for 100% of the cellular population of the 
outgrowth from tendon cultures. These outgrowths did not 
differentiate into bone, but rather produced only fibrous 
tissue. The other cell type was larger, and polygonal or 
stellate shaped, and contained significant quantities of 
alkaline phosphatase, which was absent in the spindle-shaped 
cells. These stellate cells accounted for 90% of the 
cellular population from the muscle cultures and 75% to 80% 
in the bone cultures. Chondro-osteoid (Figure 2) was found 
in 15% of the muscle and bone cultures. 
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14-15 DAYS 
FIGURE 1. Bone expiants in plasma clot on glass coverslips; 
A shows the clot with the expiant excised, B 
shows the clot with the expiant replaced by a 
plastic rod (Fell, 1932a; Fell, 1932b; Bassett, 
1962) 
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Bassett showed that by increasing the oxygen 
concentration in the atmosphere, he could increase the 
percentage of cultures that developed an osseous shell. By 
reducing the oxygen concentration, he could reduce the 
percentage of cultures developing bone to zero. In low 
oxygen atmospheres, only cartilage developed from bone and 
muscle expiant cultures. 
Another variation in the experiment Bassett performed 
was to place a square plastic rod in the center of the 
outgrowth material, just after the expiant had been removed, 
to keep the material from contracting. The square rod was 
regularly replaced by a larger rod to keep the outgrowth 
material under constant tension, as shown in Figure 1. The 
results were as shown in Figure 3. Along the sides of the 
rod, cartilaginous material formed with an osseous shell. 
However, at the corners, fibrous tendon-like tissue formed. 
Bassett's results can be summarized in the top half of 
Figure <1. When the primitive fibroblasts from the outgrowth 
are exposed to a high oxygen content and compaction (or 
perhaps just lack of tension) they form bone. When they are 
exposed to low oxygen partial pressure and compaction, 
cartilage is formed. When they are exposed to tension and 
high oxygen partial pressure, fibrous tissue forms. Bassett 
speculates that the same thing happens to primitive 
fibroblasts in the milieu of the living organism. These 
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FIGURE 2. Appearance of outgrowth from expiant after 
days (Bassett, 1962) 
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cells are directed to differentiate into cartilage forming 
cells (chondroblasts) , or bone forming cells (osteoblasts), 
or fibrous tissue forming cells (collagenoblasts), by 
tensile and compressive forces and by the partial pressure 
of oxygen present. 
In summary, Bassett (1962) stated that osteogenesis 
requires three basic elements; (1) proper cells, (2) 
adequate nutrition, and (3) proper stimulus. 
Bassett and Ruedi (1966) and Ruedi and Bassett (1967) 
performed an in vivo experiment that in many aspects models 
a single, large pore that fills with bone. Their work 
provides insights into what observations are expected in the 
porous implants that are introduced into the femurs of 
rabbits in our experiments. They cut 0.4 mm by 20 mm 
defects into the cortex of femora of adult mongrel dogs. 
The periosteum was removed; the defect was cut through one 
cortex, and the underlying medullary tissue was removed. 
The defect was isolated by a millipore filter. Slits were 
cut through the cortex on either side of the defect, and the 
millipore filter was threaded through the slits and wrapped 
over the outer opening, as shown in Figure 5. 
Animals were destroyed at various periods 
postoperative, ranging from one day to one year. The area 
around the defect was sectioned as shown in Figure 5 and 
decalcified in a formic acid, sodium formate solution. The 
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(Bassett, 1962) 
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specimens were stained for histological examination with 
hematoxylin and eosin. Van Gieson, phosphotungstic acid-
hematoxylin, and Luidlow. These stains were selected to 
distinguish collagen, fibrin, and reticulin. 
The histological examinations in the cortical regions A 
and 6 surrounding the defect showed the death of osteocytes. 
The osteocytes were shrunken and pyknotic. Many of the 
lacunar spaces were empty. Cellular elements of the 
vascular system, the haversian and Volkmann canals, were 
generally viable for longer periods, but after five days, no 
living cells were observed. At eight days postoperative, 
cortical revascularization bpgan. This started with 
resorption of the necrotic tissue followed by deposition of 
new bone. Revascularization generally occurred sooner in 
the proximal region than in the distal region. The 
endosteal 1/2 or 1/3 of the cortex usually revascularized 
faster than the periosteal part. The time required for 
complete revascularization varied from 180 days to 320 days. 
The chamber clot region remained empty in various 
animals for periods of 1, 3, 5, or 8 days. In other 
animals, it was filled with a fibrin clot in less than one 
day. After eight days there were no empty chambers, all 
were filled with fibrin. The fibrin may have formed from 
fibrinogen, and the cascade of clotting factors released by 
the ruptured capillaries of the cortex, or it may have 
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FIGURE 4» Tissue differentiation in A, tissue culture, and 
in B, in vivo (Bassett, 1962) 
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formed from fibrinogen and clotting factors that diffused 
through the millipore filter. The pores of the filter were 
0.45 /um in diameter. This size is too small to permit cells 
to pass through (red blood cells are about 7 to 8 ^ m long 
and 1 to 2.4 /im thick) , but it is sufficiently large enough 
to permit macromolecules and fluids to pass through. 
The strands of fibrin were originally parallel to the 
bony surface and the millipore filter. Occasionally, white 
blood cells were seen in the clot, but neither the 
granulocytes nor the monocytes appeared to survive more than 
24 hours. 
The fibrin clot was lysed by a centripetal invasion of 
connective tissue elements. The cellular population of the 
clot began usually at the endosteal portion of the chamber, 
and as a rule, followed the preexisting arching fibrin 
strands. For up to 30 days, closely packed capillaries 
invaded on a broad front. The capillaries were surrounded 
by large basophilic cells. Spindle-shaped cells, 
morphologically similar to fibroblasts, were seen several 
millimeters ahead of the advancing capillaries. The 
spindle-shaped cells penetrated the clot and became 
surrounded by a network of argentophilic (silver staining) 
reticulin fibers. 
This loose fibrous connective tissue was followed by a 
dense fibrous connective tissue. The denser fibrous tissue 
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PROXIMAL 
DISTAL 
FIGURE 5. Killipore defects in the cortex of rabbit femurs 
(Reudi and Bassett, 1967) 
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was less cellular. Its collagen fibers were organized in 
bundles parallel to the nillipore membrane and the long axis 
of the bone. 
The millipore isolated chamber gradually became filled 
with fibrous connective tissue that was later transformed 
directly to bone. Thus, the bone formation was a type of 
intramembranous ossification, where a membrane is replaced 
by bone, rather than endochondral ossification where 
cartilage calcifies and is replaced by bone. Sometimes 
there was bone present before all of the clot was gone. 
When the bone completely bridged the defect it first formed 
a periosteal cover, converting the chamber into an arching 
vault. 
In all specimens, the same seguence of events from 
fibrin to fibrous tissue to bone was followed. However, the 
rate that these tissues progressed through the chamber 
varied greatly. In the slowest specimen, complete bridging 
required 180 days, while in the fastest this was done in 
only 30 days. 
Polygonal cells resembling osteoblasts were seen on the 
surface of trabeculae of bone in the chamber. Away from the 
trabeculae, toward the center of the implant, fiber bundles 
were less thick and the cells more spindle-shaped. The 
tissue between the trabeculae was poor in fibers and cells, 
and rich in capillaries and wide sinusoids. Its appearance 
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was thus very different from the dense fibrous connective 
tissue. 
The first bone formed was woven bone. This woven bone 
appeared to be transformed directly to lamellar bone without 
creeping substitution. Creeping substitution is the process 
of resorption of woven bone followed by replacement with 
lamellar bone. How this direct transformation from woven 
bone to lamellar bone was accomplished is a mystery. Ruedi 
and Bassett (1967) suggest that individual osteocytes may be 
remodelling the bone in their immediate vicinity. 
The specimens in the animals destroyed after one year, 
all showed complete healing of the defect. However, 
considerable variations were seen in the earlier specimens 
in regards to the timing of events and the amount of bone 
formation. Variations were attributed to five sources. 
1. Whether or not the defect was placed in one femur 
or both femurs of the animal. If it was done in 
only one leg, the animal would avoid using that 
leg. The resulting absence of normal compressive 
and tensile forces being applied to that leg 
would hinder healing. Faster healing occurred 
when both legs were operated on and the animal 
had no choice but to use both hind legs. 
2. Variations in anatomy; long legs versus short, 
bowed legs versus straight, thick bones versus 
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thin . 
3. Variations in the vascular patterns of the bones. 
This includes both vascular variations between 
animals and within the same animal. 
U. Gross variations in the mechanical properties of 
bones of different breeds. 
5. Variations in age. Healing was generally faster 
in younger animals. 
Overall healing was more active in the proximal side 
than the distal side. The results seem to confirm that the 
inner 2/3 of the cortex is supplied by vessels that 
originate in the medullary canal, and the outer 1/3 by 
vessels from the periosteum. The arrangement of fibers was 
generally in line with the tensile stresses- This would 
indicate that piezoelectric properties of the collagen may 
be influencing bone formation. 
The progression of tissues observed in the millipore 
isolated cortical defects is illustrated in Figure 6. 
What Ruedi and Bassett (1967) observed in the millipore 
isolated defect is not identical to what is seen in normal 
fracture repair. 
In a typical fracture, the bone first responds with the 
usual tissue reaction of hemorrhage and organization of the 
clot by ordinary granulation tissue. Over time, the 
granulation tissue becomes a dense connective tissue. 
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FIGURE 6. Progression of tissues observed in the chambers 
of millipore isolated defects (Buedi and Bassett, 
1967) 
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Cartilage and fibrocartilage form within it, creating what 
is called the fibrocartilaginous callus. The 
fibrocartilaginous callus fills the gaps between the broken 
ends. Osteoprogenitor cells, of both the endosteum and 
periosteum, form new bone some distance from the fracture 
line. A meshwork of subperiosteum trabeculae begins to form 
the bony callus, with a similar network emerging from the 
endosteum. The fibrocartilaginous callus slowly erodes with 
the fibrocartilage being gradually replaced by new bone, in 
a manner similar to endochondral ossification. A bony union 
occurs when trabeculae from opposite sides of the fracture 
merge. The cancellous trabeculae then undergo compaction 
and reorganization. Excess bone is resorbed and bone is 
remodelled so that the gap is bridged with compact bone. 
Bone Induction 
Numerous bone induction experiments have been done 
using various host sites and implant substances. Ostrawski 
and Nlodarski (1971) have separated these experiments into 
three types. In one type, living tissues are used as 
inductors. These transplants can be autogenic, to the same 
animal; allogenic (or homogenic), to another animal of the 
same species; or zenogenic (or heterogenic) to another 
animal of a different species. The second type of 
experiment involves transplants of devitalized or dead 
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tissue, and the third type involves transplants of tissue 
extracts or chemical substances Injected or applied in some 
way. The living tissues that have induced bone formation 
include transitional epithelium, gall bladder epithelium, 
some stable cell lines, bone tissues, cartilage, and gastric 
fundus epithelium. 
In the Anterior Chamber of tjke Rat's Eye 
Urist and McLean (1952) performed a series of 
experiments where various tissues were placed in the 
anterior chamber of the rat's eye. The eye was used because 
it provided a readily accessible and uniform implant space 
not in direct contact with the muscular-skeletal system of 
the host. The implants were inserted through the barrel of 
a blunt 16-gauge needle. The eyes were removed at intervals 
between 6 and 36 days postoperative and fixed in a 10% 
solution of neutral formalin. The eyes were examined 
roentgenographically, by gross sectioning, and by 
histological stained sections. 
The tissues transplanted into the eye included 
periosteum, muscle, fascia, tendon, capsular ligament, bone 
marrow, cancellous and cortical bone, viable and devitalized 
fibrocartilaginous callus, various types of cartilage, and 
blood clot from a fracture. Negative results were obtained 
with implants of muscle, fascia, tendon, urinary bladder 
epithelium, ureter, and capsular ligament. None of these 
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implants showed any new bone formation or absorption of 
donor tissue. No new bone formation was seen with implants 
of specimens of the organizing hematoma from fractures of 
the shaft of the tibia. Ear cartilage and semi-lunar 
cartilage failed to induce new bone formation, although 
autogenous epiphyseal, allogenous epiphyseal, and autogenous 
articular cartilage all showed bone formation within 21 
postoperative days. Autogenous transplants from cancellous 
bone, cortical bone, bone marrow, and periosteum were all 
able to induce new bone growth to various degrees. The 
transplants of bone narrow and cancellous bone were 
organogenetic, meaning that they did not just induce the 
formation of new bone tissue, but the implants were resorbed 
and replaced by a sphere-shaped ossicle of bone with a 
primary marrow cavity and active hematopoietic tissue 
inside. The implants from periosteum, however, were classed 
as histogenetic since they produced only new bone tissue and 
not a complete bone organ. It is interesting to note that 
only the periosteum from young rats and from healing bone 
induced new bone growth. The periosteum from adult rats 
produced no new bone. Transplants from autogenous 
fibrocartilaginous callus induced new bone formation in 23 
out of 27 rats in 10 to 36 days. However, implants from 
autogenous fibrocartilaginous callus that had been 
devitalized by boiling in normal saline or by freezing with 
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carbon dioxide seldom showed new bone formation. Even when 
they did show new bone formation, it took 4 to 5 weeks to 
initiate a thick capsule of fibrous tissue with limited 
deposits of new bone. 
This was not the first time researchers had 
characterized bone induction from tissue implants. Barth 
(1893) had made observations suggesting undifferentiated 
connective tissue cells are transformed into bone forming 
cells. 
The process of new bone formation characterized in the 
eye followed the same sequence for all tissues that formed 
new bone, but not all transplanted tissues caused the 
process to carry to completion. At the end of the first 
week, the transplant was attached to the iris and 
encapsulated in inflammatory and granulation tissue. By the 
second week, a two layer capsule enveloped the transplants. 
The outer layer of the capsule was composed of dense 
connective tissue while the inner layer was composed of 
mesenchymal cells and vascular tissue. Spindle-shaped 
cells, granulation tissue, and fibrocartilage cells were 
observed in the capsule. New bone formation began on the 
surface of the implant and in the space between the vascular 
tissue of the host and the cells of the donor. It was 
difficult to observe if the cells came from the host or the 
donor, but the ingrowing perivascular connective tissue 
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cells of the host appeared to be the source. This process 
took four to five weeks to occur in transplants of cortical 
bone devoid of periosteum and marrow. Even then, new bone 
growth was observed in only two of the ten samples. In the 
four samples where they were certain the cortical bone was 
devoid of periosteum or marrow, no new bone growth was 
observed. The samples were encapsulated in fibrous 
connective tissue, and no absorption of the implant was 
observed. But the more osteogenic transplants of cancellous 
bone and fibrocartilaginous callus showed still more 
absorption of the original donor and new bone growth by the 
third week. At this point, the appearance was the same as 
seen in endochondral ossification. By the fourth week, the 
new bone formed a complete ring around the absorbing 
transplant. The outer shell changed from spongy to cortical 
bone while cancellous bone continued to be formed inside. 
In the transplants of cancellous bone, the donor tissue was 
completely absorbed by the fifth week and replaced with a 
single marrow cavity filled with active hematopoietic 
tissue. The capsule conformed to the shape of the anterior 
chamber of the eye. 
SsËESleage of Various Ussaga Sa&a aatfia 
urist et al. (1968), did a series of experiments where 
an organic matrix of teeth and bone was implanted into 
various organs. They showed that various organs and tissues 
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in the rat and rabbit display various degrees of osteogenic 
competence. Using lyophilized allogenic bone that had been 
decalcified in 0.6 normal HCl at 2 degrees Celsius for 2U 
hours, they were able to produce new bone formation in over 
90% of the implants in bone defects, bone narrow, abdominal 
muscle, quadriceps fenoris, Achilles* tendon, subcutaneous 
connective tissue, and the kidney calyx. No bone formation 
was noted in the lymph nodes, ovary capsule, adrenal, 
uterus, thymus, thyroid, or parathyroid. Intermediate 
degrees of osteogenic competence were displayed by various 
other organs, including the brain, eye, lung, pericardium, 
testes, pancreas, ovary, mesentary, and bladder. 
They more completely characterized the sequence of 
osteogenesis in bone induction than previous researchers had 
done. Although not all the steps of this sequence are 
completed in all tissues, the same pattern is always 
followed. The initial step is the invasive migration of 
cells from the host to the matrix of the implants. During 
the first five to ten days, chiefly leukocytes and 
mesenchymal cells invade the implant. After ten days in 
muscle tissue and other tissues that will subsequently 
produce new bone, there occurs proliferation of mesenchymal 
cell populations with some of the mesenchymal cells fusing 
into giant cells. This is followed by resorption of the 
matrix, and then penetration of capillary buds into the 
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resorption cavities. From 15 to 20 days after the operation 
there occurs: (1) secretion of new ground substance on the 
surface of the implanted bone matrix in its resorption 
cavities, (2) cell hypertrophy, polarization, and 
palisadization of basophilic mesenchymal cells, (3) 
pseudopodial extensions of mesenchymal cells into the 
microcaniculi system of the old matrix, (4) differentiation, 
and (5) elaboration of calcified matrix. 
Urist and his co-workers also experimented with a 
series of two stage transplants. Their lyophilized bone 
matrix was first implanted in muscle. Then after new bone 
formation was induced, it was transferred to a visceral 
organ such as the spleen, liver, or kidney. These visceral 
organs, which normally showed no osteogenic competence, 
produced new bone formation in 80% to 90% of the 
transplants. Thus, the competent mesenchymal cells from 
muscle were able to produce new bone even when they were 
transferred to an environment normally hostile to bone 
induction. 
These experiments tend to indicate that there is a 
difference in the competence, or state of readiness, of 
certain mesenchymal cells to differentiate into bone. 
Although morphologically there is no difference between 
mesenchymal cells in muscle and in visceral tissue, they are 
functionally dissimilar. Some time earlier, they had 
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diverged into different populations. 
Indu£ti£tn bx Othe£ lisgue Hatrijces 
Bone which has been demineralized in 0.6 normal HCl 
induces bone formation in over 90X of the allogenic rat and 
rabbit muscle into which it is transplanted. Other tissues 
were similarly treated with 0.6 normal HCl to test their 
inductive ability in allogenic rat and rabbit muscle. Bone 
formation was not induced by kidney, liver, muscle tendon, 
gall bladder epithelium, or stomach epithelium. It was 
induced to a small extent by urinary bladder, articular 
xiphoid, nasal septum and ear cartilage. It was induced in 
70% of the transplants of costal cartilage, and in 80% of 
the transplants of placenta. 
Certain epithelial tissues such as that of gall bladder 
and urinary bladder mucosa are known to be inductive agents. 
Transitional epithelium tissue cultures from guinea pigs 
will also induce bone formation. In some experiments 
(Friedman et al. 1968), transitional epithelium has been 
encased in diffusion chambers with millipore fibers, 150 
micrometers thick and 0.45 micrometers in diameter, and 
implanted in various tissues. The purpose of these 
diffusion chamber transplants is two-fold. One is to see if 
the induction substance will diffuse through the chamber and 
induce bone growth in the surrounding tissue. The second 
purpose is to see if induction will continue inside the 
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chamber without direct contact from the cells of the host. 
Positive results were obtained in both cases. New bone 
formation occurred both outside and inside the chambers. 
Inductive Nature of ggne 
Numerous treatments have been tried on the matrixes of 
bone and teeth to see what would alter their inductive 
ability (Wrist et al. 1969). Their inductive ability was 
destroyed by 0.6 normal NaOH, and by the chelating agents 
ethylenediamine tetraacetic acid, EDTA, and 
ethylenebis(oxyethylenenitrilo) tetraacetic acid, EGTA. The 
destruction of inductive ability by decalcification with 
chromic and osoic acids is believed to be due to oxidation 
reactions with proteins. Inductive ability was reduced by 
treatment with acids such as formalin, HCl, trichloracetic 
acid, and phosphotungstic acid. Inductive ability was also 
hampered by freezing and thawing three times, irradiation in 
excess of 1.0 Mrad., ultrasound of 20,000 Hertz, and 
ultraviolet light of 2600 to 2600 Angstroms. Induction, 
however was not hampered by 0.9% NaCl at 70 degrees Celsius, 
irradiation of only 0.2 Mrad., and 70% ether. 
The non-inhibitory treatments tend to indicate that the 
inductive substance is from extracellular protein of bone 
and not cytoplasmic tissue proteins. This is supported by 
the diffusion chamber experiments. The treatments that 
destroy the inductive properties of bone are known to cause 
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certain chemical and physical changes. These changes then 
provide clues to the nature of the inductive substance. The 
inductive properties are not destroyed by the extraction of 
lipoproteins and lipids, polysaccharides, chondroitin 
sulfates, and hyaluronate. Many of the treatments that 
destroy or limit the inductive action of the substrate share 
the common property of protein denaturization. Bone 
induction seems to be linked to the three dimensional 
structure of the crosslinked insoluble bone protein. 
Treatments that tend to destroy the quaternary structure of 
protein, reduce the inductive properties of the substrate. 
Treatments that tend to keep the covalent crosslinked 
structure intact, such as treatment with 5 molar potassium 
thiocyanate (KSCN) at 2 degrees Celsius and decalcification 
in dilute hydrochloric acid, do not hinder bone induction 
(Orist et al., 1968) . 
Metaplastic bone formation in the stroma of tumors of 
various origin is often described by histopathologists 
(Ostrawski and Wlodarski, 1971). Injection of Dunn 
osteosarcoma cell cultures in the muscles of CBA and AKR 
strains of cortisone-immunosuppressed mice almost invariably 
7 produce tumors somewhat different in composition from the 
original Dunn osteosarcoma. When triplicate subcultures of 
the same cells are freeze-dried to kill the tumor cells and 
then implanted in a muscle pouch in CBA mice, the dead cells 
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produce a unique response. Within one to two weeks, the 
host red blood vessels, macrophages, and other connective 
tissue cells resorb and replace the dead tumor cells with 
normal woven bone. By the third week, woven bone is 
infiltrated with osteoclasts, and by the fourth week it is 
remodeled into lamellar bone in the form of an ossicle 
filled with bone narrow (Urist et al. 1979b). 
Induction b% Chemical Substance 
The chemicals that have been used to induce bone 
formation include ethanol, A9NO3., CaCl2, CuSO^ , NaHPO*, 
chloric acids, quinine, and quinine hydrochloride. 
Heterotopic bone formation has been reported in man and 
rabbits after intermuscular quinine injections for malaria. 
Local irradiation by X-rays was once reported to cause bone 
formation in the lungs of rabbits (Engelstad, 1934). Some 
of the substances that produce bone formation tend to 
indicate that necrosis of muscle tissue liberates a bone 
inductor. Bridges and Pritchard (1958) investigated this by 
placing muscle fragments which had been devitalized by 
alcohol under the renal capsules of rabbits. Bone and 
cartilage formation was elicited, but such induction is easy 
to elicit in the rabbit (Ostrawski and Wlodarski, 1971) . 
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Recent Induction Studies 
Utilizing principles of induction developed by Urist 
(1965), Glowacki et al. (1981) were able to use 
demineralized bone implants for cranio-naxillofacio 
reconstruction and construction in 34 human patients. The 
clinical advantages of using demineralized bone in these 
cases include rapid union with the surrounding bone, the 
healing of large defects, avoidance of harvesting problems 
associated with removing patches of bone from the patient's 
body, and a potentially unlimited supply of banked bone. 
A study by Mellonig et al. (1981) compared the 
inductive potential of autogenous coagulun, and autogenous 
bone blend, freeze-dried allograft (FOBA) , and decalcified 
freeze-dried bone allograft (DFDBA), all applied in nylon 
chambers implanted in defects in the calvaria of 35 guinea 
pigs. In their study, both the strontium-85 uptake data and 
the histological examination indicated that DFDBA had a 
greater osteogenic potential then the other four substrates 
used (p<.001). 
Their histological examination of the nylon chambers 
showed a blood clot after the third day, and vascular 
invasion with immature connective tissue, but no new bone, 
at day seven. By the fourteenth day, some new bone began to 
appear with a greater amount seen in DFDBA chambers than in 
the other chambers. By the 21st day, still more new bone 
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was seen, particular/ in DFDBA chambers. By the 42nd and 
55th days, bone was more abundant in the DFDBA chambers. 
Large areas of osseous coagulum and bone blend were walled 
off by new bone. The control defects, which contained empty 
nylon chambers, were filled with connective tissue with new 
bone occurring only at the wound margin. 
Using demineralized bone powder and bone powder not 
demineralized, Kaban and Glowacki (1981) found demineralized 
bone powder to be the more potent induction agent in 
mandibular defects in rats. Their results were based on 
calcium-45 uptake data, gross examination, and histological 
examination. 
It is interesting to note that in many of these recent 
bone induction studies, a common theme that emerges is that 
demineralized bone is a more potent induction agent than 
mineral bone. That is true regardless of whether or not the 
bone has been lyophilized or powdered. Drist et al. (1979a) 
have used demineralized bone to isolate bone morphogenic 
protein (BMP). The periosteal activation agent used in this 
study is extracted from bone chips that were demineralized 
by a sodium chloride solution. Rather then using the 
mineral in implanted bone to be incorporated into existing 
bone, the cells of the host must first remove the mineral 
component of the implanted bone matrix. After the matrix 
has been demineralized, it is then used as a substrate for 
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new bone growth. 
Theories Concerning Bone Inaygtion 
In general, it can be said that the new bone growth 
produced by tissue implants is due to induction of the host 
cells, and not just transformation of the grafted tissue. 
The precursors of the induced chondroblasts and osteoblasts 
may be of local and/or peripheral origin. Cells resembling 
small lymphocytes infiltrate the vicinity of the inductor, 
and perhaps differentiate into osteoblasts. Ostrawski and 
Wlodarski (1971) suggest that there are two kinds of 
osteoblast precursors: one type that is genetically 
determined and forms bone tissue that is not resorbed, and a 
second kind that forms bone only under the influence of an 
inductor and can not survive long without an inductor. 
Urist et al. (1968) have commented that the inductive 
agent directs differentiation of competent hypertrophic 
mesenchymal cells like a television channel selector. Many 
authors have noted that the direction of the differentiation 
of induced cells depends upon their environmental 
conditions. Bone is formed in heavily vascularized regions, 
but chondrogenesis occurs in avascular sites of 
implantation. This is similar to the work of Bassett (1962) 
on bone formation and partial oxygen pressure. However, it 
should be recalled that osteogenesis occurred in diffusion 
chambers (Friedman et al. 1968) and that the initial step of 
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induction is chondrogenesis in a highly vascular muscular 
environment. 
Urist et al. (1968) have stressed that bone induction 
is closely related to the crosslinked pattern of the 
inductive matrix. Tissues that lack a highly crosslinked 
pattern, and highly crosslinked bone matrixes that had their 
covalent crosslinking destroyed, do not induce new bone 
formation. 
Urist has proposed that a chemical stimulus derived 
from decalcified bone and dentine elicits bone induction. 
He has theorized that this substance, that he has called 
bone induction principle (BIP) , or the bone morphogenic 
protein (BMP), is a moiety of a non-collagenous proteinacous 
nature, intimately linked to the collageneous matrix. In 
more recent published reports, Urist and Hikulski (1979) and 
Urist et al. (1979a) have claimed to have isolated a BMP. 
This was obtained by digestion of demineralized rabbit 
cortical bone matrix with bacterial collagenase. Their 
observations indicate that BMP is a glycoprotein with a 
disulfide bonded structure. The possibility exists that BMP 
is a protein aggregate. BMP is not species specific; rabbit 
BMP induces new bone formation in the rat. 
Two major theories were proposed to explain the process 
of bone induction. They are the molecular assembly conveyer 
belt theory and the semiconductor theory. The assembly belt 
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theory proposes that noncovalently bound cell exudates 
travel along a connection of intercellular polysaccharides 
and tissue specific proteins. This would explain why some 
bone formation may be seen at a site some distance from the 
transplant, but it leaves questions about the transmission 
of bone induction through a millipore membrane where, as 
described previously, inductive matrixes have been shown to 
induce new bone growth without direct contact with the host 
cells. 
The theory that has received the most attention in 
recent years is the semiconductor theory and its variations. 
These theories are based on the known effects of electrical 
current on bone growth. It has been shown that an electric 
current in the microampere range applied to bone will 
encourage bone growth at the negative electrode. In recent 
years Fukada et al. (1975) has shown that a polymer with a 
permanent electrical charge, called an electret (an 
electrical version of a magnet), will encourage bone growth 
when implanted in bone. Clinical applications of directly 
applied and directly induced electrical currents have been 
used to encourage fracture healing and healing of 
pseudarthroses in humans. It has also been shown that a 
nonuniform electrical field will cause cytodifferentiation 
of certain cells. 
This theory assumes a covalently locked-in-place matrix 
«5 
that acts as a polycrystalline semiconductor. The net 
charge on the inductive substrate is positive. The 
glycoamino acids in mesenchymal cell exudates serve as 
doping and convey a negative surface charge upon the 
mesenchymal cells. Thus, a solid state p-n junction is 
formed when a mesenchymal cell is on the surface of the 
inductive substrate. The matrix then acts as an emitter, 
the interface as a capacitor, the cell exudates as the 
diffusion media, and the hypertrophied mesenchymal cells as 
the collector. The cell membrane is the collector depletion 
layer component. The BMP would form and move like a stream 
of electrons from regions of higher to lower concentrations, 
from positive to negative and back from negative to 
positive. The polysaccharide moiety of the bone matrix may 
constitute an npn junction. The mesenchymal cells, 
including intracellular new deposits of collagen fibrils, 
may add a pnp junction to produce a forward bias at one 
junction and a reverse bias at another. Thus, circuitous or 
reciprocal inductive interactions of cells may develop 
(Urist et al. 1968) . 
An at tempt has been made by de Groot (1973) to combine 
the electrical theory and the chemical theory of bone 
induction by proposing that the BMP has a positive charge. 
The electrical theory can be described by the equations: 
M  +  e -  — 0  
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where M is mesenchymal cells, e- is the electron, and 0 is 
osteogenesis. The chemical induction theory of Orist then 
states that: 
M + BMP —^ 0 
By assuming the bone morphogenic protein has a positive 
charge, de Groot suggests: 
e- + BMP+ —BMP+(concentrated), 
BMP+(conc.) + M —^ 0 
The ability of several polymers to induce bone 
formation after they have been calcified in vivo can be 
explained by; 
matrix calcification in vivo ^  calcified matrix + 
BMP+ (conc.) , 
calcified matrix + BMP+(conc.) decalcification, matrix + 
BMP+ (conc.) 
Then, 
BMP+(conc.) + M —0 
Although much research has been-done on bone induction, 
there are not now enough basic data to establish any theory 
of induction. Bone growth by induction remains to this day, 
over 80 years after the first related experiments, a largely 
empirical phenomenon. 
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Activation of the Resting Periosteum 
Electrical effects were credited by Tornberg and 
Bassett (1977) for activation of the resting periosteum. A 
special extract prepared from the ground metatarsals and 
metacarpals of calves was shown to cause an "explosive** 
growth of bone in the periosteum of rats. This osteogenic 
extract was prepared from ground bone that was first washed 
in a sodium chloride solution, then decalcified with 
hydrochloric acid and treated with pepsin. Following pepsin 
digestion, the extract was separated from the solid residue 
and then precipitated with alcohol at 4 degrees Celsius. 
The precipitate was then lyophilized, and then dissolved in 
physiological saline at a concentration of 60 mg per ml. A 
volume of 0.1 19I was injected along the periosteal surface 
of the radius-ulna complex of adult male rats* The 
contralateral limbs received Injections of physiological 
saline as a control. 
The proliferation of new bone was almost immediate. 
Within one week, the diameter of some of the experimental 
bones doubled. Histological and electron microscopic 
examinations showed that this growth was accomplished 
entirely by the periosteum. Within 2U hours after 
injection, the cells of the deep, or cambium layer, of the 
periosteum were transformed into osteoblastic cells. Within 
another 24 hours, these cells had increased their population 
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4-fold. By the third day, multiple trabeculae of new bone 
enveloped the cortex* Leading tips of trabeculae radiated 
toward the fibrous periosteum* Palisades of osteoblasts 
were seen between the trabecular projections* By the fourth 
day, these structures were organized into recognizable 
cancellous bone. Mineralization continued until the the 
seventh day. Over the seven day period, the active cells at 
the tips of the trabeculae projections gradually transformed 
themselves into more quiescent spindle-shaped cells. During 
all this active growth, the outer, or fibrous, layer of the 
periosteum did not participate at any time. It remained 
intact, and was evidently able to stretch to accommodate the 
enlarged bone. 
Tornberg and Bassett were careful to refer to this 
phenomenon as "activation" rather than induction. It 
differed from classic induction in a couple of ways* For 
one thing, bone growth in previous induction studies took 
about 7 to 11 days to get started* In this case, it was 
completed by seven days after a phenomenal doubling of the 
bone diameter. Also, no evidence of heterotopic bone or 
cartilage formation was detected in attached muscular areas. 
Osteogenesis was confined to the cambium layer of the 
periosteum. Although they had no data to characterize the 
mechanism of this activation of the resting periosteum, they 
did strongly suggest that it may be of an electrical nature. 
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They emphasized the known electrical properties of bone, how 
an electrical current due to injury exists during healing of 
bone and how elecrical currents and electrets stimulate 
osteogenesis. They also pointed out that many long chain 
biopolymers, such as collagen and protein polysaccharides 
(proteoglycans) have fixed charge and behave as electrets. 
They suggest that the active agent may be a proteoglycan 
which is a strong, negatively charged polyanion that exerts 
its influence by means of its electret nature. 
Possible Mechanisms of Periosteal Activation 
It has been proposed that periosteal activation may be 
established by morphogens or through bioelectricity. 
Mgrghogens 
Morphogens are molecules that act as initiators or 
inhibitors of morphogenic development. They can be 
effective at extremely low concentrations. Schaller and 
Gierer (1973) demonstrated that a morphogen will stimulate 
head formation in hydra at concentrations lower then 10-io 
molar. Berking (1977) demonstrated that another substance 
exists that inhibits regeneration in hydra. It is effective 
at concentrations of less then 10-8 molar. 
The inhibitor that Berking worked with is a remarkably 
stable molecule. Its activity was not destroyed by 6 normal 
HCl at 1100 Celsius for 2U hours, by one normal MaOH for one 
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hour, by Pronase B (500 /ug/ml) at 37 degrees Celsius for two 
hours, nor by trypson (200 fiq/%1) at 37 degrees Celsius for 
U8 hours. Like PAA, it was purified from a precipitate that 
was formed in an ethanol-water solution at -4 degrees 
Celsius. Both PAA and Berking's inhibitor appear not to be 
peptides. Peptides would be destroyed by the proteases. 
These facts raise questions about PAA being, or 
containing, a similar morphogen. If the response elicited 
by PAA is caused by a single morphogen, then that morphogen 
may be a very small fraction of the total PAA extract. If 
such a morphogen is effective at concentrations of 10-* or 
10-10 molar, then the response elicited by PAA may be 
duplicated by applications of just micrograms of substance. 
Bioelësliisilï 
Lately, interest in bioelectricity has been spurred by 
the development of the vibrating probe. Lionel Jaffe 
(Purdue University) and Richard Nuccitelli (University of 
California at Davis) pioneered the development of this 
vibrating microelectrode which consists of a probe 
terminating in a platinum black ball, about 10 to 13 
micrometers in diameter. The probe measures the voltage at 
the two terminal points of its vibration. From this voltage 
drop and the resistance of the fluid, the current density 
can be calculated using Ohm's law. This probe can be used 
to measure the current field that surrounds an individual 
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cell. 
From research conducted by Jaffe and many others, it 
has been shown in a number of examples that current (defined 
as the flow of positive to negative) flows into the site 
where growth originates. Current enters at the developing 
end of fucoid embryos (Muccitelli and Jaffe, 1974) , of lilly 
pollen (Weisenseel et al* 1975), of barley root (Weisenseel 
et al. 1979), and through the regenerating, anucleate stalk 
segments of Acetabularia mediterranea (Novak and Bentrop, 
1972). 
When electrical currents have been artificially applied 
to living systems, growth and regeneration have sometimes 
been stimulated where they otherwise would not occur. An 
externally applied voltage has been able to stimulate some 
degree of limb regeneration in frogs that normally do not 
regenerate (Smith, 1967). In animals that regenerate 
naturally, this regeneration seems to be stimulated by 
currents originating in the skin. When the skin heals and 
covers the amputated stump, shorting the current source, 
regeneration will often cease (Borgens et al. 1979). Such 
regeneration has been shown to occur to a limited extent in 
humans. Children up to the age of 11 have been shown to 
regenerate the amputated tips of their fingers if the 
fingers are splinted and the skin is not allowed to cover 
the stumps too soon (Douglas, 1972; Illingworth, 1974; 
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Illingworth and Backer, 1980). In humans, artificially 
applied electrical currents and fields are used to treat 
stubborn cases of psuedarthrosls with a high degree of 
success (Bassett et al. 1977; Becker et al. 1977). 
Is the activation response of the periosteum related to 
electrical phenomena? Tornberg and Bassett (1977) have 
pointed out that PAA may contain glycoproteins. An 
electrical field created by charged glycoproteins may then 
stimulate growth and development of the cells of the resting 
periosteum. The charged glycoproteins would then be 
stimulating bone growth in much the same way that it has 
been show that implanted electrets stimulate bone growth 
(Fukada et al. 1975) . 
How then do electric fields stimulate growth and 
development in certain cells? One possible mode of action 
may be through electrophoresis of essential nutrients, 
hormones, or morphogens to the cells of Interest, and to the 
proper receptive areas within these cells. It has been 
shown that the endogenous current gradient in the oocyte-
nurse cell synctlum of Hyalophora cecropia (an insect) can 
Influence the flow of charged soluble proteins within the 
cytoplasm. Negatively charged species will flow from the 
negatively charged nurse cells into the positively charged 
oocyte, but not in the reverse direction. Conversely, 
species with a positive charge will flow from the oocyte 
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into the nurse cells, but not in the reverse direction* 
Neutral proteins migrate in both directions across the 
cytoplasmic continuum that connect the nurse cells and the 
oocyte (Woodruff and Telfer, 1980). Such electrophoresis 
may be an important step In the growth and development of 
many cells. 
The PAA that is applied to the periosteum may be 
establishing an electric field that permits such 
electrophoresis. Conversely, Instead of establishing such a 
field, PAA may be providing essential morphogenlc agents 
that are transported in such a field. PAA may be doing 
both, establishing or enhancing an electric field and 
providing morphogenlc agents to transport across the field. 
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ANIMALS, MATERIALS, AMD METHODS 
Animals 
New Zealand white rabbits were chosen as the primary 
experimental animal. Preliminary experiments on rats, 
rabbits, and puppies showed that PAA is generally more 
effective in the smaller animals. Larger mammals have 
larger bones and required a correspondingly larger dose of 
the extract, which was in limited supply. The rabbit is a 
small animal, but its femora are large enough to permit 
implant work. Since the rate of bone ingrowth and bone 
repair may be sensitive to differences in individuals 
(Weinstein et al. 1976), to minimize genetic differences 
only the New Zealand white strain of rabbits were used. To 
avoid any sexual differences, only male rabbits were used. 
Estrogen may have an effect on bone growth (Smith et al. 
1976), and female mammals may show variations in bone growth 
with the estrus cycle. 
To avoid differences that occur in the rate of bone 
repair with age, an attempt was made to use young rabbits of 
the same size. The average weight of the rabbits used in 
the two main series of experiments was 2.17 kg, with a 
standard deviation of 0.24 kg, and a range of 1.59 kg to 
2.64 kg. These were the weights at the time of surgery. 
Preliminary experiments were performed on rats. 
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rabbits, and puppies to assay the potency of the activation 
agent used. 
Porous Material 
The reguired characteristics of a porous implant 
material include compatibility with the living tissues, a 
pore structure that is well characterized and exhibits an 
average pore size large enough to permit bone infiltration, 
and sufficient mechanical strength to withstand the forces 
applied to it by the organism. All these characteristics 
are met by the high density polyethylene material, Biopore^ 
produced by Glasrockz. High density polyethylene has been 
shown to be biocompatible (Spector et al.1976; Rlawitter et 
al. 1976; Spector et al. 1979). It is available with an 
average pore size of 127 pm in diameter, which is large 
enough to permit bone ingrowth (Klawitter et al. 1976) . 
Also, preliminary work with fabrication and implantation of 
ultra high molecular weight polyethylene was performed 
(Ferguson, 1976; Alberts, 1976). 
The manufacturer produced the material as cylinders 4 
mm in diameter. At the time of surgery, they were cut to 
the appropriate length, about 8 mm, to fit through one 
2 Lot number 814112. Made from medical grade high 
density polyethylene lot number NH0677. Glasrock, 7380 
Bohannon Road, Fairburn, GA. 
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cortex and the medullary canal of a rabbit's femur. The 
pore size distribution, as found by mercury intrusion 
porosimetry by the manufacturer, is shown in Table 1. The 
average pore volume is W6.8%. 
TABLE 1. Pore size distribution of Biopore^high density 
polyethylene implants, as found by mercury 
intrusion porosimetry. 
Pores Less Than Percent,X 
350 m 92.5 
233 /im 86.2 
175 tin 65.7 
1UO urn 38.9 
117 /im 10.5 
88 ^m 9.0 
58 (tm 7.5 
35 /im 6.0 
12 3.7 
Prior to surgery, the Biopore® cylinders were washed 
with distilled water in an ultrasonic bath to remove any 
loose particles. They were washed for at least 15 minutes 
in an ultrasonic bath, and then with running distilled water 
for 5 minutes. They were not washed with a surfactant, as 
it is very difficult to remove such material from the porous 
material. Prior to implantation, the material was 
autoclaved at 1210 Celsius. 
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Extraction of PAA 
The procedure outlined in U.S. Patent 3,458,397 (Myers 
et al. 1966) was followed to obtain the activation extract 
from cancellous Immature bovine bone. Twenty kilograms of 
cancellous bone samples from waste calf ribs were shipped 
from Dubuque, lowa^. After 9 kg of soft tissue was removed, 
the bones were ground in a large meat grinder at the Iowa 
State University Meat Laboratory into particles about 2 mm 
In diameter. A total of 11.3 kg of ground bone was 
recovered. A box diagram outline of the extraction 
procedure is shown in Figure 7. 
Salt Sïtraçtlaa 
The cancellous bone was agitated in a 15X NaCl (w/w) 
solution at O*» Celsius to 40 Celsius for 13 hours. A volume 
of 1.5 liters of NaCl solution per kilogram of bone was 
used. The solvent was then removed from the ground residue 
by extrusion through cheesecloth. A second salt extraction 
was performed on the ground residue for 21 hours, and a 
third extraction for 22 hours, for a total of 56 hours. The 
sodium chloride solution used for each extract was 
discarded. The remaining residue from the cancellous bone 
weighed 9.77 kg. 
3 Blue Ribbon Foods, Ltd., 698 White Street, Dubuque, 
Iowa. 
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salt > 
solution 
clean and grind 
salt extraction 
waste soft 
tissue 
waste salt 
solution 
acid pepsin 
extraction 
36° Celsius, pH 2.4-4.0 
waste solid 
residue 
clarify fluid waste solid 
residue 
alcohol ^ alcohol extraction 
I 
h waste fluid 
freeze dry sublimated f 1 ui d 
T 
P A A  p o w d e r  
FIGURE 7. Diagram of steps used to extract PAA following 
U.S. Patent 3,458,397 (Myers et al. 1966) 
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AÇid-PeEsin Extraction 
The remaining residue was divided into two batches, and 
each batch was agitated in distilled water at 360 Celsius 
for 15 minutes. The pH was maintained at between 2*4 to 4.9 
with 6 normal HCl. Pepsin was then dissolved in the 
solution (lOg/kg of bone residue). Agitation was continued 
with a bent glass stirring rod for 45 hours. The container 
was loosely covered with parafilm which was lifted 
occasionally to adjust the pH. 
Clarification of Extract 
The acid-pepsin extract was separated from the ground 
residue by extrusion through cheesecloth. About 2.7 kg of 
solid residue remained from both batches. This solid 
residue was discarded, and over 27 liters of turbid extract 
was saved. 
The extract was centrifuged in small batches at about 
2200 revolutions per minute in a 15 cm diameter centrifuge 
(1200 X G) for 30 minutes. The solid layer was discarded, 
and a total of 26.U liters of turbid extract remained. This 
extract was then filtered through coarse filter paper. The 
pH of the clear and slightly yellow filtrate was adjusted to 
2.50 with 6 normal HCl. 
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Aiçohsl 
The clarified extract was adjusted to pH 2.5 and cooled 
to 4° Celsius. Ethyl alcohol which was cooled to -20o 
Celsius was added to produce a 30% (v/v) ethanol solution. 
The alcohol was added throughout a two minute period while 
the extract was being stirred. The extract was refrigerated 
at 4 0 Celsius overnight. In numerous batches, the extract 
was then centrifuged at 9,000 revolutions per minute in a 
0.8 cm radius centrifuge (13,000 x G) at 3° Celsius for 30 
minutes. The precipitate was saved and slurried in about 
one liter of distilled water, and the pH was adjusted to 
6.96. 
The slurry was transferred into sterile glass 
containers and lyophilized. From 11.3 kg of ground 
cancellous bone, about 65 g of freeze-dried extract was 
obtained. 
Storage 
The lyophilized powder was stored at -9^ Celsius. When 
needed, the powder was dissolved or slurried in pyrogen free 
physiological saline at a concentration of 100 mg per ml. 
£o:^eji£i Assai 
The potency of the extract was assayed by injecting 
varying amounts of the PAA along the periosteal surface of 
the radius-ulna complex of mature, 200 g, male rats and 
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along the periosteal surface of the femurs of male rabbits 
and male puppies. A week later, each animal received a two 
microCuries intrathoracic injection of strontium-85 HCl. 
The animals were killed the next day, and the radioactivity 
of their bones that had received the PAA extract was compar­
ed to the activity of the control contralateral bones that 
had received an injection of pyrogen free physiological sa­
line, Since strontium is absorbed by growing bone, the ratio 
of the activity of the experimental limb to the activity of 
the control limb gave a measure of the potency of this batch 
of extract. The potency of the substance was expressed by 
the formula; 
(experimental femur - bkg) / (control femur - bkg) 
X 100 = Potency Value. 
Potency values above 100 indicate enhanced osteogenic 
activity in the treated bone. This radio-tracer technique 
is similar to what other groups have used to measure new 
bone growth relative to a control (Myers et al. 1966; 
Mellonig et al. 1981; Kaban and Glowacki, 1981). A brief 
review of radiation statistics with examples is given in 
Appendix A. 
In the potency assay on the rabbits in Table 4, a 
special technique was performed to optimize the counting 
geometry. The midshafts of the femurs were ashed and ground 
into a powder that was placed in test tubes of uniform size. 
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The hase of each test tube was then mechanically lowered 
into the well detector of a Picker deep well counter that 
was used for all the radiation measurements in this study. 
If the rabbit femurs were counted whole, the part of the 
femur near the top of the well would not be counted as well 
as a part deep in the well of the detector. The radiation 
measured from a given source decreases proportionally to the 
inverse of the square of the distance of the detector from 
the source. To provided all potency samples with a more 
uniform and homogenous geometry, samples were powdered and 
placed in the bottom of test tubes of uniform size. The 
data from these samples are expressed as ratios of counts 
per minute per milligram of sample. 
For the rest if the study (i.e., the endosteal 
activation series, the implant series, the empty defect 
series, and other potency assays), ashing the radioactive 
bone sampler was not performed for three reasons. First, 
ashing the radioactive samples and grinding them into a 
powder was hazardous work. Second, the ashing and grinding 
technique destroyed the sample, making it unavailable for 
histological examination. Third, adequate geometry for 
radiation counting could be acquired by sectioning the 
samples into small segments, and counting each segment 
individually. 
For the data in Table 5 and for the rest of the 
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radiation data, the counting geometry was improved by 
dividing the femur into smaller sections so that the pieces 
were in contact with the detector, but separated. The main 
disadvantages of this method are that it does not homogenize 
the samples as well, and it does not provide as uniform a 
geometry as the ashing method does. A discussion of the 
counting geometry and the self-absorption problem is given 
in Appendix B. 
Sterility *ssa% 
A culture test performed on the extract in a petri dish 
showed no bacterial growth after three days. 
Surgery 
In the empty defect (ED) series and the implant (I) 
series, aseptic surgery was performed on the rabbits so 
holes could be drilled in their femurs. The rabbits were 
anesthetized with intermuscular injections of acepromozine 
maleate* (16 mg/kg of body weight), xylazine hydrochlorides 
(3 mg/kg of body weight) , and ketamine hydrochloride* (50 
mg/kg of body weight) . Acepromozine, a tranquilizer, was 
Bristol Laboratory, Division of Bristol-Myers Co., 
Syracuse, N.Y. 
5 Rompon, Baynet Division, Cutter Laboratories, Inc., 
Shawnee, Kansas. 
Fort Dodge Laboratories, Inc., Fort Dodge, Iowa. 
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the first one injected. Five minutes later, the xylazine 
and ketamine were injected. Xylazine is an analgesic drug, 
and ketamine is an anesthetic drug. 
The surgical area over the femur was shaved and 
scrubbed. The subcutaneous fat and superficial fascia were 
excised directly under the skin incision. The fascia lata 
that connects the biceps femoris muscle and vastus laterolis 
muscle, were incised along the cranial border of the biceps 
femorous muscle. Gelpi clamps were used to retract the 
biceps muscle caudally and to retract the vastus latus 
muscle to excise the fascial intermuscular septum between 
these muscles on the lateral side of the bone. When the 
bone was exposed, incisions were cut in the periosteum so 
that a flap of periosteum could be folded away from the area 
to be drilled. Holes, U mm in diameter, were then drilled 
in each femur using a hand operated drill and bit. The 
defects were drilled through the cortex and through the 
medullary canal, but not through the opposite cortex. Two 
defects were drilled in each femur. The first defect was 
drilled 20 mm distad from the third trochanter, and the 
second defect was drilled 20 mm distad from the first 
defect. 
To optimize data which could be collected for each 
rabbit, a maximum of 2 holes were drilled in each femur. A 
greater number would have resulted in a high incidence of 
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failure due to fracture. 
In the ED series, the holes were left empty, while in 
the I series the defects were filled with a Biopore® 
implant. The empty defects were designed to permit the 
observation of the effects of PAA on a reproducible defect. 
The geometry of other types of defects that could have been 
used, such as a fracture or a chip, would have been difficult 
to repeat exactly. A fracture defect would have caused 
other complications. The animal would have needed a cast, 
or braces, or bone plates to aid healing and to avoid 
unnecessary suffering to the animal. The purpose of using 
the Biopore® implant was to examine the effects of PAA on 
bone ingrowth into a porous implant. The implant was first 
pressed into the defect until its end abutted against the 
opposing endosteum and the other end protruded out of the 
defect. The point where the cylindrical implant met the 
outer edge of the lateral cortex was marked on the implant. 
The implant was then removed, and the implant was cut at 
that point. The shortened implant was then pressed back 
into the defect so that it was flush with the periosteum of 
the femur and it did not protrude out of the defect. 
Illustrations of positioning of the implants into the 
defects are shown in Figure 8 and Figure 9. 
The flap of periosteum was then carefully placed back 
over the defect, or over the implant in the defect, without 
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FIGURE 8. Exposure of femur showing the distal defect 
FIGURE 9. Femur showing a protruding cylindrical implant 
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suturing it. The wound was sutured shut in three tiers of 
sutures. The fascial lata was first sutured to the cranial 
border of the biceps femoris muscle in one tier,? the 
subcutaneous fat and fascia were sutured in the second and 
the skin was sutured in the third tier*. 
An identical surgery, with either empty defects or 
implants, was then performed on the contralateral femur. In 
each animal, one femur served as the experimental femur 
while the other served as the control femur. 
So as not to interfere with bone growth and repair, no 
antibiotics were given to the animals after surgery. 
Periosteal Application of PAA 
Seven days after surgery had been performed on both 
femurs (long enough to permit healing of the periosteum), 
pyrogen free physiological saline containing 100 mg of PAA 
per ml of volume was injected along the periosteal surface 
of the experimental femur. The contralateral control femur 
received an identical injection of the same saline, but 
without any PAA. The PAA was applied so that 400 mg was 
delivered per kg of body weight. Thus, a rabbit that 
7 Silk or polypropylene. Ethicon, Inc., Somerville, 
N .J. 
8 Vetafil. Processed from imported materials by S. 
Jackson, Inc., Washington B.C. 
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weighed 2 kg received an Injection of 8 ml of fluid in each 
femur. This dosage was selected on the basis of results 
from the potency assay. Both the PAA saline solution and 
the control saline solution were Injected using sterile 18 
gauge needles. The needle was pierced through the overlying 
skin and muscle. The surgical wound was not reopened to 
apply PAA. The third trochanter was palpated to use as a 
reference point for the placement of the needle. The first 
defect was 20 mm distad from the third trochanter and the 
second defect was 40 mm distad. Half of the solution was 
injected over the site of the proximal defect and the other 
half over the site of the distal defect. The solution was 
extruded from the needle with the bevel of the needle held 
flat to the periosteal surface of the bone while the needle 
was pulled from proximal to distal, from about one cm above 
the defect to about one cm below the defect, passing over 
the defect. This motion was repeated until half of the 
solution for that femur had been extruded, and then the rest 
of the solution was similarly applied over the other defect 
in the femur. 
Experimental Series 
Three series of experiments were performed, the empty 
defect (ED) series, the implant (I) series, and the 
endosteal activation (EA) series. These series can also be 
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compared with the rabbits used in the potency assays. In 
the potency assays, there were a set of rabbits that had PAA 
applied to the periosteum of one femur without any previous 
surgery. The contralateral femur was a control. There were 
also rabbits in the potency assays that did not have any PAA 
applied to either femur. In the ED series, two holes 4 mm 
in diameter and 20 mm apart were drilled in the femurs. 
They were drilled through the lateral cortex and through the 
medullary canal, but not through the opposite cortex. The 
holes were left open without an implant being inserted. 
Seven days after surgery, WOO rag of PAA per kg of body 
weight were injected along the periosteal surface of one of 
the femurs and an equal volume of pyrogen free saline was 
injected along the periosteal surface of the contralateral 
femur as a control. The rabbits were then sacrificed at 
periods of 1, 3, 5, 7, 10, and 14 days after the application 
of PAA. Three rabbits were used for each time period. 
The implant (I) series was performed exactly as the ED 
series, except in the I series, porous implants were placed 
in the holes drilled in the femurs. As in the ED series, 
PAA was injected along the periosteal surface of the femurs 
one week after surgery at a dosage of WOO mg per kg of body 
weight, and the contralateral femur was used as a control. 
In the I series, the rabbits were sacrificed at periods of 
1, 3, 5, 7, 10, m, and 56 days. Three rabbits were used 
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for each time period. 
The endosteal activation (EA) series was a study of the 
effects of PAA on the endosteum. Although Tornberg and 
Bassett (1977) had stated that PAA only affected the 
periosteum, it actually had not been applied to the 
endosteum in that study. Since the endosteum is also an 
active participant in bone growth and repair, it was decided 
that it would be worthwhile to specifically investigate its 
effect on the endosteum. 
The endosteal application of PAA was accomplished by 
inserting a long 18-gauge needle into the medullary canal, 
through a hole punched in the trochanter fosse (at the 
proximal end of the femur). PAA was then slowly injected as 
the point of the needle was moved from the distal to the 
proximal end of the medullary canal. This was repeated 
until all of the PAA had been applied. 
The first rabbits that received an endosteal 
application of PAA, received it a week after defect surgery 
had been performed on them as in the ED series. Holes, R mm 
in diameter, were drilled in their femurs and left open. 
This preliminary procedure for the EA series was abandoned 
due to a high mortality of rabbits. Nearly all of the 
rabbits involved died from an anaphylactic-type response 
within hours after the intermedullary application of PAA in 
a dosage of 300 mg to UOO mg per kg of body weight. 
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However, due to an unusually high activation ratio in the 
one rabbit that did survive this preliminary procedure, it 
was decided to continue with a modified EA series. This 
rabbit had an activation ratio for the entire femur of 
2.361, which is higher than any activation ratio in either 
the I or ED series. 
In the modified EA series, survivability of the rabbits 
was improved by implementing three changes in the procedure. 
First, the rabbits did not suffer the trauma of a defect 
surgery as was done in the ED series or the I series. 
Except for the small hole needed to permit entry of an 
18-gauge needle, holes were not drilled in the femurs of the 
EA series rabbits. Second, to prevent embolism, an amount 
of medullary material and fluids equal to the volume of 
fluid to be injected was removed from the medullary canal of 
each femur immediately prior to the application of PAA. 
Third, the amount of PAA applied was reduced to 100 mg per 
kg of body weight. In the endosteal activation series, 
rabbits were sacrificed at time periods of 1, 3, 5, 7, and 
10 days. At least four rabbits were sacrificed at each 
time period. 
72 
Characterization Procedures 
Gigss Exaiilaation 
When the rabbits were killed and their bones were 
removed, observations were recorded of the gross appearance 
of the bones and overlying soft tissues. Measurements were 
also made with a micrometer to estimate the surface area and 
volume of the midshaft region of representative specimens 
from the femurs of male rabbits, the femurs of male rats, 
and the radius-ulna complex of male rats used in this study. 
The surface area was estimated by assuming the cross 
sectional surface area of the bones to be elipses. For each 
measurement, an average was made from three specimens. 
Strontiua-85 Tracer. Segmenting, and Sectioning 
Twenty-four hours before an animal was killed, it was 
given an intrathoracic injection of 0.2 microCuries of 
strontium-85. Then, after an animal was killed with an 
overdose of sodium pentobarbital,* the PAA treated femurs 
and control femurs were removed, cleaned of excess tissue, 
and fixed in neutral buffered formalin. Material was stored 
in buffered formalin for periods up to 14 days. The control 
femurs were the contralateral femurs that had experienced 
the same surgery, but had not received any PAA. 
9 Sleepaway, Fort Dodge Laboratories, Inc., U713 D 
Street, Fort Dodge, Iowa. 
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Each femur was cut into three test segments as shown in 
Figure 10. When cutting these segments, the blade of a 
Stryker saw was guided by pre-cut grooves in a plexiglass 
template to give segments of reproducible length. The "mid" 
segments were always 10 mm long and were located midway 
between the defects. The "proximal" segment contained the 
proximal defect, and the "distal" segment contained the 
distal defect. The proximal and distal segments were always 
15 mm long. This type of sectioning allowed most of the 
midshaft of the femur to be counted for strontium-85 decay. 
proximal mid- distal 
segment segment segment 
15 mm '"l5 mm' 
10 mm 
FIGURE 10. Division of femur into three segments. 
Each segment was placed in a separate test tube with 2 
ml of neutral buffered formalin. Each test tube was then 
counted in a Picker deep well counterio that was adjusted to 
selectively measure gamma rays of an energy characteristic 
10 Picker Nuclear Autowell 11, Automatic Sample Changer. 
Intertech, Inc., 333 State Street, North Haven, Connecticut. 
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for strontium-85 decay. The counter was adjusted by placing 
a strontium-85 standard in the counter and adjusting the 
appropriate potentiometers until the maximum count rate was 
obtained. Identical test tubes, containing 2 ml of neutral 
buffered formalin with similar bone segments taken from 
rabbits not treated with strontium-85, were used to measure 
the background radiation. From these counts, an activation 
ratio was calculated for each segment (Myers et al. 1966) 
such that: 
(Count from a segment from the experimental femur -
background)/ 
(Count from identical segment from the control femur -
background) 
= Activation Ratio 
Such a ratio adjusts for slight differences in the amount of 
strontium individual rabbits may have received, and also 
adjusts for differences due to radioactive decay in samples 
that could not be counted at the same time after harvesting. 
However, when the samples were counted, paired samples from 
the same rabbit were always counted within minutes of each 
other. An activation ratio greater then 1.0 indicates 
enhanced bone growth in the experimental femur, and one 
equal to or less than 1.0 indicates no enhanced bone growth 
in the experimental femur. 
The uptake of strontium by bone occurs primarily by two 
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methods. One method is through incorporation into new bone, 
and the other method is by surface exchange and diffusion 
with calcium and strontium in the extracellular fluid into 
old bone. A study by Elves (1974) attempted to measure the 
fraction of strontium tracer that was in the bone due to new 
bone formation. He showed that after 2U hours, 78.6% of the 
strontium taken up could not be washed away by elution with 
CaCla* It can be assumed that most of this "non-elutable" 
strontium had been incorporated into new bone. The problems 
of the counting geometry and self-absorption by the sample 
are discussed briefly in Appendix B. 
Demineralization and Prefiaration for Staining 
After the segments from the rabbits had been counted, 
the segments from some of the rabbits were selected for 
microscopic histological examination and for computerized 
image analysis to measure the amount of bone ingrowth. The 
samples from 7 rabbits from the ED series, 13 rabbits from 
the I series, and 7 rabbits from the EA series were selected 
on the basis of having exceptionally large or exceptionally 
small osteogenic values. At least one rabbit was selected 
from each time period of each of the series. From these 
rabbits, the proximal and midsegments were demineralized in 
ethylenediamine tetraacetic acid (EDTA) so that they could 
be thin-sectioned and stained for histological examination. 
The distal segments from the ED series and the I series were 
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stained and denineralized using Lillie's silver impregnation 
technique for bone (Lillie and Fullmer, 1976) so that the 
amount of bone ingrowth into the implants could be 
quantitatively measured using computerized image analysis, 
lillie's technique stains only calcium bearing tissues 
black, which makes it ideal for computerized image analysis. 
The demineralizing proximal and midsegments were kept 
on top of cotton matting inside of test tubes filled with 
EDTA. The cotton matting kept the samples near the top of 
the EDTA solution to enhance demineralization. The EDTA 
solutions were changed every three days. The total 
demineralization procedure took about two months. Personnel 
from the Environmental Health and Safety office of Iowa 
State University verified at the end of the demineralization 
process that the bone samples did not have radioactivity 
significantly above background levels. 
When completely demineralized, the proximal and 
midsegments were cut with a razor blade so that a microscope 
section could be taken from the desired plane. The proximal 
section was cut through the center of the defect as shown in 
Figure 11. A 6 pm thin section was then taken from the 
plane perpendicular to the long axis of the bone, through 
the center of the implant or defect. 
A similar section was taken from the nidplane of the 
midsegment as shown in Figure 12. 
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proximal 
- — cut 
distal 
defect, 
cortex > 
FIGURE 11. Transverse slice and cross section from proximal 
segments 
tp 
FIGURE 12. Transverse slice and cross section from mid 
segment 
Stains 
The primary stains used in this study were hematoxylin 
and eosin (H and E) and Lillie's silver impregnation 
technique (Lillie, 1928). The H and E stain was applied to 
demineralized tissues and the Lillie*s silver stain was 
applied to hard samples. 
appearance of 
cross section 
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Hematoxylin and eosin is probably the stain most 
frequently applied to demineralized bone. The bone matrix 
absorbs the eosin stain which turns the matrix a pinkish 
red. New woven bone tends to have more of a purple hue. 
Basophilic tissues such as cell nuclei absorb the blue 
hematoxylin stain. 
Lillie's silver impregnation technique uses silver 
nitrate. To enhance penetration of the silver nitrate, the 
bone samples were cut into sections 2 mm thick with a 
jewelers saw and treated in a silver nitrate solution at 37o 
Celsius for two weeks. After the stain had been applied, 
the samples were demineralized in Ebner's decalcification 
solution (Lillie, 1928). The complete procedure followed is 
listed below: 
1. 70% alcohol, one day 
2. 90% alcohol, one day 
3. 100% alcohol, one day 
U. 100% benzene, one day to remove fats that may 
interfere with absorption of the silver nitrate 
stain 
5. 90% alcohol, one day 
6. 70% alcohol, one day 
7. distilled water, one day 
8. 2.5% (w/w) silver nitrate solution in a water 
bath at 31° C, two weeks with one change of 
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solution 
9. Ebner's decalcification solution (150 ml sodium 
chloride saturated distilled water, 150 ml 
distilled water, U.5 ml concentrated HCl). Each 
sample was placed in 6 ml of Ebner's 
decalcification solution, and every day 0.06 ml 
of 3 normal HCl solution was added to each sample 
until it was demineralized, typically 90 days for 
samples this size. 
10. Rinse in half saturated sodium chloride solution, 
four days 
11. Rinse in running tap water, one day 
12. 70/5 alcohol 
The samples were then embedded in paraffin and thin-
sectioned. 
Lillie's silver impregnation technique stains all 
calcium bearing tissues black, while other tissues are left 
either unstained or stained light brown. It is a treatment 
that clearly distinguishes bone, but not new bone from old 
bone . 
For the hematoxylin and eosin stain, cross sections cut 
from the EDTA demineralized samples were stored in 10% 
neutral buffered formalin for at least 2U hours. They were 
then taken through increasing solutions of alcohol, 70%, 
95%, and absolute, to dehydrate them. Before being embedded 
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in molten paraffin, they were soaked in xylene to remove the 
alcohol. Thin sections six micrometers thick were cut from 
the paraffin blocks with a microtome. The thin sections 
were mounted on microscope slides and soaked in the 
following series of solutions: 
1. Xylene 
2. Absolute alcohol 
3. 95% alcohol 
4. 70% alcohol 
5. Distilled water 
6. Hematoxylin 
7. Acid alcohol 
8. Lithium carbonate 
9. Distilled water 
10. Eosin 
11. 95% alcohol 
12. Absolute alcohol 
13. Xylene 
A series of special stains were applied to 
corresponding control and experimental femur samples from 
the 7 day period of the endosteal activation series. One 
sample was taken from each leg. Once a sample was 
demineralized and embedded in paraffin, a minimum of five 6 
fin thick sections were cut from it, and each section was 
stained with a different dye. The stains used on this 
I 
! 
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sample comparison were: Gomori's reticulin to bring out 
reticular fibers, Masson's trlchrome for collagen fibers and 
fibrin, periodic acid-Schiff for carbohydrates, alcian blue 
at pH 1.0 fop sulfated glycoaminoglycans, and alcian blue at 
pH 2.5 for glycoaminoglycans, in general. The procedures 
for each of these special stains are given in the Manual of 
Histological Staining Methods of the Armed Forces Institute 
of Pathology, Third Edition (Luna, 1968). 
Gomori's reticulin (Gomori, 1937) is a silver stain 
that is used to distinguish reticular fibers which are 
stained black, while collagen fibers are stained red or 
purple. 
Masson's trichrone (Masson, 1929) stains collagen 
fibers either green or deep blue. Cartilage and bone are 
stained lighter shades of blue, and fibrin is stained red. 
Periodic acid-Schiff (PAS) (McManus, 19UB) reacts with 
carbohydrates, turning them red. Fibrin shows as red to 
pink. 
Alcian blue (Lev and Spicer, 196U) is a stain for 
glycoaminoglycans. At pH 1.0 it is selective for sulfated 
mucosubstances, while at pH 2.5 it is a general stain for 
mucosubstances. 
These stains will distinguish certain fibers, tissues, 
and substances that may be involved in new bone formation. 
For example, an increase in glycoaminoglycans, particularly 
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sulfated glycoaminoglycans, Is associated with the early 
development of bone in the mammalian fetus. In endochondral 
ossification, bone is first formed by cartilage cells of 
chondrocytes. After the chondrocytes begin to mineralize, 
they hypertrophy and are replaced by a vascularized front of 
new bone formation. Hasson's trichrome stain can illustrate 
these steps. Reticular fibers found in medullary tissue may 
or may not be involved in bone formation in this study. 
Where there are cells that are very active, there may be an 
enhanced presence of carbohydrates, and this can be 
illustrated by the PAS stain. 
Image Analysis 
The purpose of using image analysis was to 
quantitatively measure the area of new cancellous bone 
growth seen in the microscope slides from the empty defect 
and implant series and to measure the area of bone ingrowth 
in the slides of the implants from the implant series. The 
area of cancellous new bone was measured from photographic 
enlargements of the slides using an electronic planimeter, 
the MOP-III,i* for the proximal and distal segments, and 
measured directly from slides using the HOP-llI in 
conjunction with the camera lucida for the midsegments. A 
camera lucida is a simple light tube that projects an image 
** Carl Zeiss, Inc., UUU 5th Avenue, New York, NY. 
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onto a surface. The measurements of the areas of bone 
ingrowth were made with the Quantimet® Image Analysis 
Computeriz from photographic enlargements of the implant 
areas stained by Lillie's silver impregnation technique for 
bone « 
The microscope slides from the proximal and distal 
segments were photographed with Kodak Technical Pan film 
2415*3 with a Zeiss "Tessovar" photomicroscope**. The 
slides stained with hematoxylin and eosin were photographed 
through a Kodak gelatin filter No. 13G (green), at a 
magnification of 2.5, and with the automatic shutter set at 
an ASA of 37.5. The slides stained by Lillie's silver 
impregnation technique (only distal segments) were 
photographed with no filter, and with an ASA setting of an 
automatic shutter of 25. A magnification of 2.5 was used if 
the entire sample was being photographed; a magnification of 
(i was used if just the implant was being photographed. The 
film was developed in a 1:1 solution of D-76 developeris for 
eight minutes, then placed in Kodak stop bath for 30 
seconds, and followed by two minutes in Kodak rapid fixer. 
imanco. Image Analysis Computers, 40 Robert Pitt 
Drive, Monsey, N.Y. 
Eastman Kodak Company, Rochester, N.Y. 
Carl Zeiss, Inc., U44 5th Avenue, New York, N.Y. 
Eastman Kodak Company, Rochester, N.Y. 
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before being rinsed in running water for about 5 minutes. 
Prints of the slides were made on 20.3 cm by 25.4 cm (8 
inches by 10 inches) Kodak polycontrast R.C. or Kodabrome II 
B.C. paper. With each roll of film, at least one photograph 
was made of a ruler to determine the actual magnification of 
the final print. 
An electronic planimeter, MOP-III, was used to measure 
the area of apparent new cancellous bone seen on both 
photographs of the H and E stained slides and the slides 
stained by the lillie's technique. The photographs were 
placed on a special table that carried magnetic fields which 
were sensed by a stylus. The stylus was then used by the 
operator to outline the perimeter of the tissue being 
measured. As the stylus moved, it sensed the surges of 
magnetic fields that moved in the X and Y directions. The 
magnetic surges were counted by the MOP-III computer and 
translated into X and Y coordinates. The computer was 
programed to use these coordinates to calculate the area of 
the space outlined by the user operated stylus. 
With the H and £ stained slides, tinctural guides and 
cement lines were used to outline the apparent parimeters of 
the new bone formation. On the slides stained with the 
Lillie's technique, there were no intermediate shades of the 
stain; the tissue was either stained deep black or hardly 
stained at all. On these slides, less information was 
85 
available to outline the general area of new cancellous 
bone. Separate measurements were kept of new bone that 
formed on the periosteum of the samples, and bone that 
formed on the defect or inside the medullary canal. The 
area of new bone on the slides from the midsegments could be 
more conveniently measured by using the camera lucida** in 
conjunction with the MOP-III. This technique eliminated the 
need to photograph the slides. A light emitting diode was 
affixed to the end of the stylus used to mark the outline of 
areas on the MOP-III table. The camera lucida projected the 
image of this light on to the image of the slide as viewed 
by the operator through the microscope. By moving the 
stylus around on the MOP-III table, the operator, with some 
practice, could make the image of the light appear to travel 
along the border of the tissue of interest seen in the 
slide. When the projected light image had completely 
encircled this tissue, the MOP-III gave an area measurement 
that was calibrated to the actual area of the tissue seen in 
the microscope. 
The Quantimet®Image Analysis computer was used to 
measure the area of bone Ingrowth in the implants from the 
silver nitrate stained distal segments. lillie's silver 
impregnation technique for bone was selected for this 
Carl Zeiss, Inc., 445 5th Avenue, New York, N.Y 
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because It stains deep black only calcium bearing tissues. 
Photographic enlargements were made of the implant in these 
segments, and the area of the implant was cut out of each 
photograph. The photographs of just the implant areas were 
provided to Barry Hitman*?. Using the Quantimet@ image 
analysis computer. Nr. Hitman measured the total area of the 
deep black phase on each photograph and the percentage of 
the photograph covered by the deep black phase. 
A Quantimet® image analysis computer works by dividing 
a viewing surface into as many as 605,000 picture points. A 
densitometer determines the light intensity at every picture 
point, and assigns to each a six bit binary code between 1 
and 63, equivalent to the true log of the optical 
absorption at that point. A range setting system can then 
extend the optical density range up to 3.00 optical density 
units. The operator then selects an optical threshold that 
separates the darkly stained calcified material from the 
more lightly stained non-calcified material, so that nearly 
all of the calcified area lies on one side of the threshold 
and the uncalcified area on the other side of the threshold. 
The computer can then be commanded to give the number of 
picture points that fall in the dark area and the number 
that fall in the light area. The Quantimet®system includes 
Barry Hitman, College of Dentistry, The University of 
Iowa, Iowa City, Iowa. 
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a television screen that illustrates the areas of different 
light intensity on the slide. This television image gives 
the operator feedback on what the computer is classifying as 
"bone". The threshold can be adjusted until the best fit is 
reached. 
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RESULTS 
Potency Assays and Preliminary Experiments 
Since different extacts of PAA display different 
potencies, a new potency assay must be done for each 
extract. Potency values from rats, using PAA from a trial 
batch, and PAA from the extraction used in this study are 
shown in Tables 2 and 3, respectively. Similar potency 
experiments were performed on the femora of puppies and of 
rabbits to examine its effects on different species. These 
results are shown in Tables 4, 5, and 6. 
In Table 2, the potency values obtained from each 
individual rat generally increased with increasing dosage of 
PAA until a plateau was reached at about 120 mg/kg of body 
weight. In Table 3, the potency values obtained for a 
dosage of 125 mg/kg of body weight were similarly greater 
than those obtained with a dosage of 75 mg/kg of body 
weight. However, the potency values from the batch of 
extract used in Table 3, were less then those obtained from 
slightly smaller dosages in Table 2. This would indicate 
that the batch used in Table 3 (which was also used in the 
ED, I, and EA series) may have been somewhat less potent 
than the batch obtained from the trial batch used in Table 
2 .  
Tables U and 5 contain the results of potency assays 
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TABLE 2. Potency values obtained from 200 g male rats using 
a trial batch of PAA 
Rat mg Injected mg Injected per Potency Value 
number kg Body Height 
1 0 0 95 
2 0 0 106 
3 6 30 147 
U 6 30 121 
5 12 60 190 
6 12 60 231 
7 24 120 319 
a 24 120 393 
9 48 240 367 
10 48 240 306 
done on rabbits. The results are from a trial batch of PAA 
and from the batch of PAA used in this study, respectively. 
Potency values tended to peak at dosages of 300 mg/kg to 600 
mg/kg, and declined at dosages of 1000 mg/kg and 1500 mg/kg. 
The potencies of these particular extracts are considerably 
less than that used by Tornberg and Bassett (1977). They 
were able to get about the same results using 1/40th the 
concentration we used. The potency of PAA is known to vary 
from batch to batch, perhaps due to different concentrations 
in the bones of different individual animals (R. C. 
Millonig, The Squibb Institute for Medical Research, 
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TABLE 3. Potency values obtained from 200 g male rats using 
the extract of PAA used in the ED, I, and EA 
series 
Rat rag Injected mg Injected per Potency Value 
number kg Body Weight 
1 0 0 98 
2 15 75 136 
3 15 75 1U8 
4 25 125 21 3 
5 25 125 301 
Princeton, N. J. 08510, personal communication), and perhaps 
due to differences in laboratory techniques and equipment. 
In addition to the strontium-85 data, a gross 
examination was made of the rabbit femurs listed in Table 5. 
The femurs were rated 0, +, ++, or +++, depending upon the 
amount of periosteal new bone growth seen in the 
experimental femur compared to the control. A mark of 0 
means that the experimental femur did not show any more 
periosteal new bone than the contralateral control, + means 
that the active experimental femur has one or two small 
nodules of periosteal new bone, ++ means that it had one or 
two large masses of periosteal new bone, and +++ means that 
it had massive amounts of periosteal new bone. 
To test the effect of PAA on another species, a potency 
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TABLF 1. Potency values obtained from male rabbits using a 
trial batch of PAA 
Rabbit Dosage Potency value from Potency value 
number (mg per kg of ashed bone, adjusted prior to ashing 
body weight) for the dry weight 
of the ashed residue 
1 0 79.2 103.4 
2 0 90.8 87.9 
3 100 104.7 109.3 
W 100 162.3 123.0 
5 150 85.7 99.1 
6 150 120.3 116.6 
7 200 130.6 116.3 
8 250 117.U 100.2 
9 250 1U5.7 130.6 
10 300 145.2 112.2 
11 300 125.2 126.2 
12 500 119.6 134.8 
13 500 131 .0 136.9 
14 1000 109.7 106.3 
15 1000 94.7 109.5 
16 1500 115.6 117.7 
17 1500 89.3 120.9 
assay was performed on two puppies. The puppies were both 
males and weighed 3 to 4 kg. The results from these two 
puppies (Table 6) were similar to the data from the rabbits 
in that similar dosages of PAA applied resulted in similar 
potency values. For the higher dosage used here, a high 
9 2  
TABLE 5. Potency values and gross examination grades from 
male rabbits using the extract of PAA used in the 
ED, I, and EA series 
Rabbit Dosage Potency Gross examination 
number (mg/kg body weight) value grade 
1 0 108.5 0 
2 0 102.8 0 
3 200 110.9 + 
4 200 111.6 + 
5 200 118.3 + 
6 400 198.6 + ++ 
7 UOO 116.0 +++ 
8 WOO (died the 6th day) +++ 
9 600 170.1 ++ 
10 600 106.4 ++ 
11 600 235.0 ++ 
TABLE 6. Potency values from femora of two puppies 
Amount injected Potency value 
(mg/kg body weight) 
99.5 118 
354.0 176 
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potency value was obtained. 
Based on the results of these potency assays, it was 
decided that for the main experiment, PAA would be applied 
at a concentration of 400 mg per kg of body weight (mg/ka). 
A dosage of 400 mg/kg showed the most new bone growth in the 
gross examination (Table 5) and was in the range of the 
higher potency values in Tables U and 5. Overall, these 
preliminary experiments showed that although PAA accelerated 
the uptake of strontium-85 in the rabbit, it did not do it 
as spectacularly as it did in the much smaller rat. The 
difference was also noticeable grossly. In the rat, the 
diameter of the radius-ulna complex would nearly double, 
while in the rabbit the effect was noticed as localized 
nodules of periosteal new bone. A much higher dosage of PAA 
in terms of mg per kg of body weight had to be given to the 
rabbit or the puppy to produce a noticeable effect. This 
may be due to a difference in the surface to volume ratio of 
the tested bones of these animals. A periosteal activation 
agent would be expected to have a more noticeable effect on 
bones that have more periosteum in comparison to their total 
size. An examination of a sampling of rabbit bones and rat 
bones from these experiments produce surface to volume 
ratios shown in Table 7. 
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TABLE 7. Ratios of surface area to volume estimated for 
various bones 
Bons Area Volume Area/volume* 
(mmZ) (mm3) (mm-*) 
Femur, 2 ka 
male rabbit 1013 1979 0.51 
Femur, 0.2 kg 
male rat 240.3 212 1.13 
Radius-ulna 
0.2 kg male rat 177.4 63.2 2.81 
iSse page 72 for procedure, 
Gross Examination 
Rabbits from the Potency Assa% as a Control Grou& 
The rabbits from the potency assay can serve as a 
control to the I and ED series, since the former are rabbits 
that recieved a periosteal application of PAA in one femur 
without a previous defect or implant surgery. 
The rabbits in the potency assay were all killed seven 
days after the application of PAA. Observations of these 
rabbits showed similarities with the I and ED series at day 
7. Exudate formation and some fibroplasia vas often seen in 
the muscles adjacent to the femur that had received the PAA 
(the experimental femurs). Such exudate formation was not 
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observed adjacent to the femurs that received the application 
of saline (the control femurs). 
Small areas of periosteal new bone growth were observed 
in thp experimental femurs, but not in the control femurs. 
At an apolication of 200 mg of PAA per kg of body weight, 
there was usually just a few scattered nodules of new bone 
on the midshaft of the experimental femur. The new bone was 
usually concentrated in irregularly shaped nodules about 2 
to U mm long, 1 to 2 mm wide, and protruding about 1 mm 
above the smooth surface of the midshaft of the bone on the 
side of the femur that had received the application of PAA. 
The periosteal new bone seemed to be most extensive in 
femurs that received an application of about mg PAA per 
kg body weight. At an application of 400 mg/kg, the nodules 
of periosteal new bone merged into a large mass that covered 
about a fourth of the surface area of the diaphysis. At a 
concentration of 600 mg/kg, the periosteal new bone was more 
extensive than at 200 mg/kg, but was less extensive than at 
UOO mq/kg. At 600 mg/kg, the experimental femurs generally 
had one or two large nodules of periosteal new bone about 3 
to 6 mm wide, by 3 to 6 mm long, and protruding about 1 mm 
above the smooth surface of the femur. 
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EmEti Defect and ImRlant Series 
At one day after application of PAA, the muscles and 
loose areolar tissue surrounding the femur were loosely 
separated and filled with blood or a bloody fluid. This 
phenomenon was usually more extensive in the experimental 
femur. In one animal, a large clot was observed under the 
skin sutures. 
At day three after application of PAA, exudate forma­
tion and some fibroplasia was seen in the muscle adjacent to 
the bone and in the subcutaneous tissue in the experimental 
leg. Some blood or watery fluid was still occasionally seen 
in the muscle adjacent to the bone in both femurs. 
At days 5, 7, 10, and 1U after application of PAA, a 
yellow-gray to white-gray or a pink-brown exudate was almost 
always seen in the leg with the experimental femur. In one 
rabbit, exudate was seen in the control femur directly under 
the skin suture. This was probably a reaction to the suture 
or a bacterial infection through the skin. Besides that 
example, there were no other rabbits that showed a exudate 
formation in the control leg. The exudate that almost al­
ways formed in the experimental leg could be found directly 
under the skin, in the underlying muscle, or in a mass in 
the muscles adjacent to the femur. Often it was scattered in 
all three areas. There were only a few animals at these 
time periods that did not show exudate formation in the 
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experimental leg. No exudate was observed at day 56. 
Periosteal new bone growth could be grossly observed in 
both the control and experimental femurs at all time periods 
from day one to day 14 in both the ED series and the I 
series. At the early time periods of days 1,3, and 5, the 
femurs often showed extensive amounts of cartilaginous 
callus around the defect area. Sometimes these calluses 
completely covered the defects. 
At longer time periods of 7, 10, and 11- days there 
tended to be less of the soft cartilaginous calluses. These 
femurs, both control and experimental, tended to have ridges 
or lumps of periosteal new bone around the areas of the 
defects. By day 10 and day 14, the defects in the ED series 
were becoming filled with new bone. At days 10 and 14 in 
the I series, the new bone often partially covered the 
implant. Often the new bone growth made it impossible to 
locate the defects or the implants in the 10, 14, and 55 day 
samples. In many of these samples, the location of the 
defect was found from X-ray photographs of the samples. At 
day 56, the lumps and ridges of new bone were no longer 
prominent. 
Endosteal Activation Series 
In the endosteal activation series, the formation of 
exudate was confined to the muscles and soft tissues in the 
area of the trochanter of the activated femur. No callus 
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formation was observed on the outside of any of the bones. 
Summary of ths EsntEâlateEal Esatrol Sg£ies 
With the exception of one rabbit, exudate formation was 
not observed in any of the control legs. In the one control 
leg where exudate was observed, it appeared to be associated 
with the skin sutures and not with the femur or the muscles 
adjacent to the femur. 
Nodules of periosteal new bone were not observed in any 
of the control femurs from the potency assay in any of the 
animal species examined. 
Periosteal calluses and nodules of periosteal new bone 
were, however, observed in the controls from the ED and I 
series. At the early time periods of 1, 3, and 5 days in 
the ED and I series, cartilage calluses were often seen 
around the defect areas. Sometimes the defects and implants 
were completely covered by these calluses. At the longer 
time periods of 7, 10, and 14, days, ridges or lumps of 
periosteal new bone were often seen around the defects and 
implants. At days 10, 1U, and 56, new bone often partially 
covered the implants. At day 10 and 14, the empty defects 
were becoming filled with bone. By day 56, the lumps and 
ridges of new bone were no longer prominent. 
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Strontium-85 Tracer 
Control GrouB T; Potency Assax on Rabbits at Zero PAA 
In the potency assay, there were four rabbits that 
received a zero application of PAA. In other words, a 
saline solution was applied to the periosteum of both femurs 
in each of these rabbits. These rabbits were all treated 
with an intrathoracic injection of strontium-85, 2U hours 
before they were killed. They were all killed seven days 
after application of PAA. 
Activation ratios can be calculated from the 
radioactivity of these femurs by either taking the ratio of 
the left femur over the right femur, or the ratio of the 
right femur over the left femur after subtracting background 
in both cases. The results of left/right ratios are listed 
in Table 8. The averages are all from femurs that were 
not ashed. 
The average of both types of ratios came very close to 
1 .000. The activation ratio calculated from the left femur 
in the numerator is 1.007, with a standard deviation of 
0.089, and a standard deviation of the means of O.OSW. 
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TABLE 8. Activation ratios at seven days after an 
application of 0 mg of PAA per kg of body weight 
(unashed bones) 
Rabbit Left/right 
1 1.03% 
2 0.879 
3 1.085 
U 1 .028 
Average 1 .007 
Standard 
deviation 0.085 
Standard deviation of the means = 0.0U4 
These means are exactly what is expected. In the 
absence of any specific stimulation to just one femur, but 
not the other, both femurs are expected to be near mirror 
images of each other. Their average activation ratios 
should be very near 1.000. 
The standard deviation of about 0.085 indicates that 
within individual rabbits, there can be some difference 
between their contralateral femurs. The averages of near 
1.000 indicates that these differences may be averaged out 
of a large group of rabbits. 
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control GrouE II: Pfitençi Assays on Rabbits at Dosages of 
UOO M £AA ner kg of Body Weight 
Another control group that can be identified in the 
potency assay is the rabbits that received an application of 
400 Dig of PAA per kg of body weight. We should restrict the 
comparison to rabbits that received the same extract of PAA 
used in the ED, I, and EA series* There were two such 
rabbits that such activation ratios were calculated for, and 
these are shown in Table 9. The average activation ratio 
for these two rabbits is 1.573 with a standard deviation of 
0.584. 
The rabbits in the potency assays were all killed seven 
days after the application of PAA. It would then be 
reasonable to compare them to the seven day rabbits in the 
ED and I series which also received 400 mg PAA/kg. The 
activation ratios of all rabbits from day 7 in the ED and I 
series are repeated in Table 9. 
Table 9 shows that the day 7 rabbits from the I and ED 
series had nearly identical average activation ratios (1.12 
for the I series and 1.126 for the ED series). These values 
were similar to the average activation ratio of the potency 
assay where 200 mg PAA per kg body weight was injected 
(1.136). The average values for I and ED series are 
considerably less then the average of the 400 mg/kg values 
from the potency assay. 
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TABLE 9. Activation ratios of rabbits killed 7 days after 
an application of 400 ng PAA per kg body weight 
compared with the activation ratios from the 
potency assays 
Rabbit Series Dosage Activation Average 
number (ng/kg) ratio ±95% C.I.* 
1 ED 400 1.035 
2 ED 400 1.155 1 .120 
3 ED 400 1.186 ±0.134 
4 I 400 1.186 
5 I 400 1.123 1 .12 
6 I 400 0.816 ±0.52 
9 pot.assay 200 1 .109 
10 pot.assay 200 1.116 1.136 
11 pot.assay 200 1 .183 ±0.024 
12 pot.assay 400 1.986 1.573 
13 pot.assay 400 1 .160 
14 pot.assay 600 1 .701 
15 pot.assay 600 1 .064 1 .705 
16 pot.assay 600 2.350 ±1 .08 
. e — confidence interval. 
SaBly Dgfegt Se£i£s 
Table 10 shows the activation ratios from the empty 
defect series where the PAA was applied to femoral defects 
without porous implants. The results are expressed as a 
simple ratio of the activity of the experimental femoral 
segment divided by the activity of the corresponding control 
segment after subtracting the background radiation from both 
counts. Appendix A gives an analysis of the radiation 
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statistics involved, and an example of how the activation 
ratio was calculated. The table also gives the results for 
the femoral midshaft where the activities of all three 
segments taken from the femur were added; the ratio is the 
sum of the activated segments divided by the sum of the 
control segments. 
Figure 13 displays the data from the total of the 
segments of the empty defect series. Figure 1U presents the 
data from the proximal segments. Figure 15 from the 
midsegments, and Figure 16 from the distal segments of the 
ED series. The total bone averages for each time period are 
displayed in Figure 17. 
The data from Figure 17 show that the rate of enhanced 
bone accretion is fairly constant at all time periods except 
for the peaks at day 5 and day 14. The peak at day 1U is 
particularly interesting because previous literature 
(Tornberg and Bassett, 1977) had described the activation 
effect as being completed at 7 days. The peak at day 5 is 
more consistent with the observations of Tornberg and 
Bassett (1977) . They stated that mineralization occurred 
as early as 60 hours after application of PAA, and continued 
until 7 days after application. 
The graphs for the individual segments. Figures 14, 15, 
and 16, all show considerably more scatter of data than the 
graph for the combined segments data. Figure 13. This is 
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TABLE 10. Activation ratios from the empty defect series 
Day Sample Proximal Mid- Distal Total Average 
number segment segment segment segments of total 
femur, 
± 95% c.; 
1 I 1 .170 0.895 1 .329 1.151 
TV 1.048 0.894 1 .145 1 .048 X=1 .113 
VI 1 .094 1.027 1 .265 1 .141 ±0.094 
3 I 1 .370 1 .234 0.991 1.196 
II 1 .223 0.984 0.820 1 .014 X=1 .116 
III 1.220 1 .142 1 .151 1 .181 ±0.150 
5 II 1 .148 0.992 1 .638 1 .247 
III 1 .318 1 .708 1 .847 1 .577 X=1 .41 
IV 1 .727 1 .115 1 .192 1 .392 ±0.28 
7 I 2.157 0.793 0.543 1.035 
TV 1 .064 1 .064 1 .344 1.155 X = 1 .126 
V 1.121 1 .375 1 .141 1 .1 86 ±0.134 
10 II 0.794 0.872 1 .556 1.103 
III 1 .452 0.967 0.830 1 .063 X=1 .090 
IV 1 .363 1 .324 0.757 1.105 ±0.040 
14 I 2.003 2.348 1 .492 1 .862 
II 1 .432 1 .692 2.282 1 .813 X=1 .58 
IV 0.300 1 .146 1 .41 5 1 .058 ±0.76 
Average of all total segments = 1.240*0.105 
iC.I. = confidence interval. 
expected, since in any given region of bone there can be 
growth, resorption, or little change going on as part of the 
normal remodelling process. As a whole, a bone may appear 
to keep the same silhouette as it grows from a small bone in 
the infant to a large bone in the adult; various segments of 
i . Q l  I  I  t I I  I  I  I  I  I  I  I  
0 5 10 
Days after Application of PA A 
FIGURE 13. Activation ratios from the total midshaft (sum 
of distal, mid, and proximal segments) of femurs 
from the ED series 
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the bone must go through a complicated pattern of growth and 
resorption cycles to maintain that profile. At any given 
time, one part of a bone may be undergoing resorption, 
whether it be for growth, remodelling, repair, or the 
stresses applied or transmitted at that area, while the 
identical segment in the contralateral bone may be 
undergoing some other process. In any large number of 
rabbits that were not treated with PAA, we would expect 
roughly half to have activation ratios slightly above 1.0 
and half to have activation ratios slightly below 1.0. 
In the data for the smaller segments, we see both 
values above 2.0 as in days 7 and 14 for the proximal 
segments, day 14 for the midsegments, and day 14 for the 
distal segments, as well as some values less than 1.0. The 
activation values that are less than 1.0, occur mainly in 
the midsegments where there are 7 such values; in the 
proximal segments there are 2, and in the distal segments 
there are 4. This may be due to our technique of applying 
PAA, which tended to concentrate it at the sites of the 
defects in the proximal and distal segments. 
imEiaat series 
Table 11 shows the activation ratios for the implant 
series where PAA was applied to femoral defects with porous 
implants in them. Figure 18 displays the activation ratios 
for the combined segments. Figures 19, 20, and 21 display 
0 5 10 
Days after Application of PAA 
FIGOBB 1«. ictl.ation ratios fto. the proximal segnents 
from the ED series 
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the activation ratios for the proximal, mid, and distal 
segments, respectively* Figure 22 displays the mean 
activation ratios for each time period in the implant 
series. 
Perhaps the most noticeable characteristic about the 
activation ratios from the implant series is their extreme 
variability. The combined midshaft values in the ED series 
were all greater than 1.0, but in the implant series, six of 
the 18 rabbits slaughtered at time periods from 1 to 14 days 
give ratios less than 1.0, which means there was more new 
bone growth in the control than in the active implant. The 
only time period where all three rabbits gave ratios greater 
than 1.0 was at day 1. 
The activation ratios for the proximal, mid, and distal 
segments. Figures 19, 20, and 21, respectively, also reflect 
the greater variability of the implant series. For the 
proximal segments there are 7 activation ratios less than 
1.0, for the midsegments there are 6, and for the distal 
segments there are 5. For the 21 rabbits studied, one-third 
of the bone segments from the implant series gave activation 
ratios less than 1.0. 
In the implant series, as in the empty defect series, 
there were two rabbits at the 14 day interval that produced 
very high activation ratios. This indicates again, that PAA 
may be activating bone growth up to two weeks after its 
I L 
0 5 10 
Days after Application of PAA 
FIGURE 15. Activation ratios from the mid segments from the 
ED series 
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application. However, there is a large standard deviation 
for the m-day group in the implant series. The mean value 
at 14 days is not statistically significant at the 95% 
confidence level. Only at the one day period in the implant 
series do we find an activation ratio mean that exceeds 1.0 
by more than the 95% confidence interval. 
Endosteal Activation Series 
For the endosteal activation series, the rabbits 
received an endosteal injection of PAA through the 
trochanter fosse, without the trauma of defect surgery. The 
first rabbit injected in this series was one out of three in 
a test to see if the rabbits could survive such an 
application of PAA. Out of the three initial rabbits that 
received the endosteal application, rabbit I in the day 7 
group was the largest (3.18 kg), and was the only one to 
survive. Due to the extremely high activation ratio that 
was obtained from this rabbit, it was decided to continue 
with a modified EA series. That rabbit had received an 
injection of about 300 mg of PAA per kg of body weight. No 
medullary fluid or tissue was aspirated prior to the 
application of PAA. 
Another series of three rabbits (rabbits II, III, and 
IV in the day 7 group) were then given a lower dosage of PAA 
(100 mg per kg of body weight) after an equal volume of 
medullary fluid and tissue had been aspirated. The 
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FIGURE 16. Activation ratios from the distal segments from 
the ED series 
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aspiration of medullary tissue was done to prevent possible 
embolism from the large volume of fluid injected. Since all 
three of these rabbits survived, the remaining rabbits in 
the EA series all received a similar application of PAA 
after an equal volume of medullary tissue and fluid had been 
aspirated. 
For the EA series (Table 12), there is a very wide 
scatter of data that include both very high values, up to 
2.67, and very low values, down to 0.518, for activation 
ratios. In general, the total activation ratios of less 
than 1 .0 occurred mostly at the 1 and 3 day periods. Out of 
22 rabbits completed in the EA series, 7 gave activation 
ratios for the total femoral shaft of less than 1.0, one 
gave a ratio of 1.000, and 14 produced total activation 
ratios greater than 1.0. Of the seven rabbits that gave 
total activation ratios less than 1.0, five of them were 
from the one and three day groups. 
Perhaps there is a tendency for PAA to actually hinder 
endosteal bone growth during the first three days after 
application. However, due to the large standard deviation in 
the data, no statement can be made about this with a high 
degree of statistical confidence. The activation ratios 
measured in series EA, both the high ones and the low ones, 
may be totally random. 
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TABLE n .  Activation ratios from the implant series 
Day Sample Proximal Mid - Distal Total Average, ; 
number segment segment segment segments of total 
segments, 
±95% C.I. 
1 I 1 .31 2 1 .288 1 .388 1 .331 
TI 0.939 1 .481 1 .261 1 .1 27 X=1.30 
III 1 .634 1 .614 1 .081 1 .439 ±0.27 
3 I 0.973 1 .1 76 1 .290 1.112 
11 1.314 1 .096 1.095 1 .183 X=1 .03 
III 0.755 0.718 0.921 0.799 ±0.34 
5 I 0.835 0.777 0.837 0.821 
III 1 .157 1 .514 0.829 1 .083 X=0.92 
IV 1.012 0.959 0.645 0.868 ±0.24 
7 I 1 .491 1 .740 1 .153 1.433 
II 0.745 1 .096 1 .859 1 .123 X = 1 .12 
III 0.654 0.81 2 1 .160 0.810 ±0.52 
10 I 1 .545 1 .1 32 0.555 0.912 
II 1 .449 1 .102 1 .279 1 .332 X=1 .13 
VI 1 .257 1 .237 1 .018 1 .1 57 ±0.35 
1« I 1 .302 1.374 1 .367 1 .340 
11 1.037 0.881 0.647 0.820 X=1.30 
III 1 .41 8 2.372 1 .684 1 .734 ±0.78 
56 I 1 .064 1.433 1 .070 1.128 
II 0.967 0.686 0.680 0.814 X=1 .01 
III 0.709 1 .2284 1 .434 1 .091 ±0.29 
Averaa® of day 1 through day 14 total segments = 1 .135±0 .1 09 
iC.I. = confidence interval. 
Image Analysis 
Image analysis was done on a selection of samples from 
the E*) and I series. It was decided to perform a general 
8 
O 5 10 
Days after Application of PA A 
FIGURE 18. Activation ratios from the total midshaft 
femurs from the I series 
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survey for these series by microscopic examination and image 
analysis of only one or two samples from each time period in 
each of the two series. The choice of which rabbit samples 
would be examined was made on the basis of the activation 
ratios of their total femur segments. In the ED series, 
where all of the total activation values were above 1.0, it 
was decided to usually take the rabbit from each group that 
had the highest activation ratios. The rabbits chosen were 
the ones numbered 1-1, 3-III, 5-III, 7-1, 7-V, 10-IV, and 
14-1. In the seven day group, it was decided to take an 
additional rabbit, 7-1, that showed a wide variation in the 
activation ratios from individual segments. In the I 
series, there was at least one rabbit that had a total 
activation ratio of less then 1.0 for each time group, with 
the exception of the day 1 group. In the I series, image 
analysis and microscopic examination was done on samples 
from the rabbit at day 1 that had the highest total 
activation ratio, rabbit l-III, and on the rabbits that had 
the highest and the lowest activation ratios in each of the 
other time periods, rabbits 3-II, 3-III, 5-1, 5-III, 7-1, 
7-III, 10-1, 10-11, 14-11, 14-III, 56-1, and 56-11. 
The image analysis methods were another way of 
measuring the amount of new bone growth. The strontium-85 
tracer method could detect the amount of new bone in a given 
volume of bone segment. The two image analysis methods both 
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FIGDRE 19. Activation ratios from the proximal segments 
from the I series 
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attempted to measure the amount of new bone seen in 
microscope slides made of cross sections of bone segments. 
In a way, the strontium-85 tracer method measures new bone 
growth in three dimensions, and the image analysis methods 
identify new bone growth in two-dimensional plane sections. 
Tables 13 through 20 display the image analysis data 
obtained from the MOP-III. The amount of new cancellous 
bone seen in each slide is measured in mmz. The ratio of 
the new bone in the activated femur to the new bone in the 
control is calculated for each pair of corresponding 
segments. For slides from the proximal and distal segments, 
the new bone is divided into various categories. In the 
empty defect series, the amount of new bone formed on the 
periosteum of the bone, the amount of new bone formed inside 
the medullary canal and, the amount of new bone formed in 
the defect were counted separately. In the implant series, 
the new cancellous bone was divided into (1) periosteal new 
bone, (2) new cancellous bone in the medullary canal, but 
not within the implant, and (3) new bone within the implant. 
For the distal segment of the implant series, the new bone 
within the implant was measured using the Quantimet®image 
analysis computer. The correlation coefficient, r, was 
calculated for each segment of each series for the 
activation ratios found with the strontium tracer method 
versus the ratios of the image analysis techniques. Where 
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FIGURE 20. Activation ratios from the mid segments from the 
I series 
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the new bone formed was divided into different categories, 
the correlation coefficient was calculated for each 
category. Ratios were omitted from the correlation data if 
either the denominator or numerator were zero or close to 
zero. How the correlation coefficient was calculated is 
shown in Appendix C. 
The new bone ratios calculated from the hematoxylin and 
eosin stained slides from the implant series correlated very 
highly with the activation ratios found from the strontium 
tracer measurements (r = 0.825 for the proximal segments of 
the implant series, 99% confidence interval = 0.30 to 0.98, 
Table 17; r = 0.852 for the midsegments of the implant 
series, 95% confidence interval = 0.25 to 0.9W, Table 19). 
The correlation was less for the H and E stained slides from 
the empty defect series (r = 0.470 for the proximal segments 
of the ED series, 95R confidence interval = -.UO to 0.85, 
Table 18; r = 0.660 for the midsegments of the ED series, 
95% confidence interval = -.17 to 0.92, Table 19), and very 
poor for slides stained by Lillie's silver impregnation 
technique (r = 0.065 for the distal segments of the empty 
defect series. Table 16; and r = 0.3U5 for the distal 
segments of the implant series. Table 21). 
The poor correlation between the strontium tracer data 
and the Lillie's silver stained slides may be due to the 
lack of information the stain provides to distinguish new 
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FIGURE 21. Activation ratios from the distal segments from 
the I series 
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bone. With Lillie's silver impregnation method for bone, 
there are no gradations in intensity due to different types 
of bone. Also, it does not show cement lines that can 
establish the border between new bone and old bone. The 
Lillie's method stains black all the calcium bearing tissue 
that is penetrated by the stain. 
Although the correlation was not as good for the H and 
E stained slides of the empty defect series as it was for 
the implant series, it should be noted that with the 
exception of the one day sample from the empty defect 
series, that whenever the strontium tracer data found the 
activated femur to be more radioactive than the control, the 
NOP measurements also found more new bone on the slide from 
the activated segment than the slide from the control 
segment. In this study, we have used the correlation 
coefficient, r, which is a measurement of linear 
correlation. 
In the proximal segments from the empty defect series. 
Table 13, most of the new cancellous bone was seen "inside", 
in the medullary canal or in the defect area, with the 
exception of samples from rabbits 7-1 and 14-1 where large 
calluses of new bone were seen "outside" or on the 
periosteal surface. The outside new bone in these segments 
correlate modestly with the strontium data (r = 0.40, 95% 
C.I. = -.50 to + .85), while the new bone formed on the 
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FIGURE 22. Average activation ratios from the total 
midshaft of femurs from the I series 
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TABLE 12. Activation ratios from the endosteal activation 
series 
Sample Proximal Mid- Distal Total 
number segment segment segment segments of total 
segments 
±95% C.I, 
1 I 1 .193 0.92% 0.793 1 .017 
II 0.989 0.660 0.%5% 0.733 
GO 00 o
 
II X
 
III 0.95U 0.9%8 0.875 0.763 ±0.1 8 
IV 1 .0W3 1 .036 0.936 1.010 
3 I 0.91 9 0.922 0.3%6 0.730 
II 1 .039 0.781 0.870 0.919 X=0.91% 
III 1 .798 1 .639 1.176 1 .489 ±0.%9 
IV 0.548 0.510 0.%81 0.518 
5 II 1 .56U 1 .1 30 2.%35 1 .716 
IV 1 .U72 1 .325 1 .378 1 .367 X=1.30 
V 1 .066 1 .0U3 0.896 1 .000 ±0.36 
VI 1 .036 1.213 1 .1 98 1.132 
7 12 2.U7 2.%6 2.18 2.361 
II 1.58 1 .67 5.06 2.67 X=1 .51 5 
III 0.858 1 .257 1 .0%3 1 .020 ±0.65 
IV 0 . 8 m  0.821 0.740 0.803 
V 0.852 1 .155 1 .709 1 .198 
VI 1 .038 0.740 1 .241 1 .038 
10 I 2.02% 1 .21% 1 .32% 1 .616 
II 0.61% 0.U%% 0.610 0.590 X=1.29% 
III 1 .U68 1 .916 1.6%6 1.573 ±0.56 
IV 0.953 2.072 1 .791 1 .398 
Average of all total segments = 1. 212±C.198 
ic.l. = confidence interval. 
ZThis rabbit had a slightly different treatment, 
see text on page 69-70. 
inside showed essentially no correlation with the strontium 
data (r = -.1U). now the correlation statistics were 
125 
TABLE 13. Areas of new cancellous bone measured with HOP-
III electronic planlmeter In the empty defect 
series, proximal segments (H and E stains) 
Rabbit 
femur 
(r=right 
l=left) 
ratio 
(active/control) 
New bone 
external 
to defect 
(mmZ) 
1-1 
active=r 2.076 
control=l 1.202 
ratio (a/c) 1.727 
3-III 
active=l 5.604 
control=r 2.613 
ratio (a/c) 2.145 
1U-I 
actiwe=r 
control=l 
ratio (a/c) 
10.893 
3.363 
3.239 
New bone 
inside 
defect 
(mm2) 
3.973 
5.031 
0.790 
6.910 
8.489 
0.814 
1 .062 
1.300 
0.817 
Total 85sr Activation 
new bone ratio 
(mm2) 
6.049 
6.233 
0.971 
12.514 
11.102 
1.127 
5-III 
active=l 4.671 8.203 12.874 
control=r 1.787 6.636 8.423 
ratio (a/c) 2.614 1.236 1.528 
7-V 
active=r 2.965 11.488 14.453 
control=l 1.735 7.068 8.803 
ratio (a/c) 1.709 1.625 1.642 
7-1 
active=r 9.708 4.356 14.064 
ccntrol=l 6.260 3.333 9.593 
ratio (a/c) 1.551 1.307 1.466 
10-IV 
active=r 5.497 9.805 15.302 
control=l 3.045 4.576 7.621 
ratio (a/c) 1.805 2.142 2.008 
11.540 
4.663 
2.546 
1 .17 
1 . 2 2  
1 .727 
1 .121 
2.157 
1 .363 
2.003 
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TABLE 14. Correlations of the MOP-III measurements with the 
strontium-85 activation ratios for the proximal 
segments of the empty defect series 
New bone Mew bone Total 
external Inside new bone 
to defect defect 
r = 0.4022 -0.136 0.470 
r 2  =  0 . 1 6 2  0 . 0 1 8  0 . 2 2 1  
calculated is explained in Appendix C. It should be 
remembered that the strontium-85 data measures the total 
activity of the bulk sample. This activity is due mostly to 
strontium-85 being incorporated into new bone, but some of 
it is also due to strontium-85 interchanging with calcium in 
old bone. The MOP-III data measures what appears to be new 
bone in a two-dimensional slide. Therefore, perfect 
correlation is not expected between the two methods, but 
some correlation is expected. Since the strontium-85 data 
shows enhanced radioactivity due to new bone, we expect to 
see some of this new bone on the two-dimensional slides. 
In the midsegments, nearly all the new cancellous bone 
observed was on the periosteal surface of the bone. The 
midsegments were 10 mm segments midway between the two 
defects. The midsegments from the ED series. Table 15, had 
a correlation with the strontium tracer data of 0.660, 9 5 %  
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TABLE 15. Areas of new cancellous bone measured with the 
MOP-III electronic planimeter in the empty defect 
series, midsegments (H and E stain) 
Rabbit Area of new a^Sr activation 
femur cancellous bone ratio 
(l=left (mm2) 
r=right) 
ratio (active/control) 
1 - 1  
active=r 0.86 
control=l 1.80 
ratio (a/c) 0.478 0.895 
3-III 
active=l 3.44 
control=r 2.68 
ratio (a/c) 1 .287 1 .142 
5-III 
active=l 6.08 
control=r 2.33 
ratio (a/c) 2.61 1.708 
7-1 
active=r 4.17 
control=l 6.36 
ratio (a/c) 0.656 0.793 
7-V 
active=r 8.18 
control=l 5.25 
ratio (a/c) 1 .558 1 .375 
10-IV 
active=r 8.39 
control=l 3.29 
ratio (a/c) 2.55 1.324 
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TABLE 15 (Continued) 
Rabhit Area of new 8SSr activation 
femur cancellous bone ratio 
(l=left (mmZ) 
r=right) 
ratio (active/control) 
14-1 
active=r 17.89 
control=l 9.26 
ratio (a/c) 1.932 2.348 
r = correlation of total areas of new bone with the 
strontium-85 activation ratios 
r = 0.66 9 5 %  confidence interval = (-0.17,+0.92) 
r2 = 0.44 
C.I. = -.15 to +.90. The two samples from the midsegment of 
the ED series that had an activation ratio less than 1.0 
with the strontium tracer, also had a ratio of less than 1.0 
with the image analysis data. 
The image analysis data from the distal segments of the 
ED series. Table 16, showed virtually no correlation with 
the strontium tracer data. This was probably due to 
limitations caused by the silver stain used on the distal 
segments. These slides had less information to distinguish 
new bone from old bone. 
The data from the proximal segments of the I series. 
Table 17, showed a high correlation with the strontium data 
(r = 0.825, 99% C.I. = +.30 to +.99). As in the slides of 
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TABLE 16. Areas of new cancellous bone measured with the 
MOP-III electronic planimeter in the empty defect 
series, distal segments (Lillie's silver 
impregnation technique). 
Rabbit 
femur 
(r=right 
l=left) 
ratio 
(active/control) 
New bone 
external 
to defect 
(mm2) 
New bone 
inside 
defect 
(mm2) 
Total ®ssr Activation 
new bone ratio 
(mmZ) 
1 - 1  
active=r 0.754 7.629 8.363 
control=l 0.982 2.400 3.382 
ratio (a/c) 0.768 3.179 2.479 
3-III 
active=l 1.293 7.291 8.584 
control=r 3.300 7.696 10.996 
ratio (a/c) 0.392 0.947 0.781 
5-III 
active=l 4.453 3.518 7.971 
control=r 2.389 5.713 8.102 
ratio (a/c) 1 .864 0.616 0.984 
7-1 
active=r 2.407 2.572 4.979 
control=l 4.800 2.485 7.285 
ratio (a/c) 0.500 1.035 0.683 
7-V 
active=r 5.804 6.778 
control=l (damaged)1 9.441 
ratio (a/c) 0.718 
10-IV 
active=r 2.315 2.051 
control=l 0.579 3.922 
ratio (a/c) 3.998 0.523 
12.582 
6.237 
2.630 
2.371 
1.329 
1.151 
1 ,847 
0.543 
1.186 
0.757 
iThis sample was destroyed in the thin sectioning 
process with the microtome. 
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TABLE 16 (Continued) 
Rabbit New bone New bone Total Activation 
femur external Inside new bone ratio 
(r=rlght to defect defect (mmZ) 
l=left) (mmZ) (mmZ) 
ratio 
(active/control) 
14-1 
actlve=r 2.713 5.535 0.248 
control=l 2.530 1.598 4.128 
ratio (a/c) 1.072 3.464 1.948 1.492 
r = correlation of total new bone with 8SSr 
activation ratios 
r = 0.065 
r2 = 0.004 
the proximal defects of the ED series, this high degree of 
correlation was due almost entirely to the periosteal new 
bone on the samples (r = 0.898, 9954 C.I. = +.45 to +.98). 
No correlations were found for both the new bone tissue 
inside the medullary canal (r = 0.22) and inside the implant 
(r = 0.13). Unlike the proximal segments from the ED 
series. Table 13, most of the new bone observed in most of 
the proximal segments of the I series. Table 17, was 
periosteal new bone. The midsegments of the I series. Table 
19, showed a high correlation with the strontium tracer data 
(r = 0.852 for up to day 7, 95% C.I. = +.25 to +.99). The 
fact that the strontium-85 data correlates highly to the 
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TABLE 17. Areas of new cancellous bone measured with the 
NOP-lII electronic planimeter in the implant 
series, proximal segments (H and £ stains) 
New bone New bone 
Rabbit external inside 
femur to implant implant 
(r=right (mmZ) (mraZ) 
l=left) 
ratio 
(active/control) 
New bone Total 
inside new bone BSSr 
medullary (mmZ) Activation 
canal ratio 
(mmZ) 
l-III 
active=r 2.906 
control=l 0.122 
ratio (a/c) 23.82 
3-III 
active=l 1.415 
control=r 4.055 
ratio (a/c) 0.349 
5-1 
active=r 2.964 
control=l 4.052 
ratio (a/c) 0.732 
0.071 
0 . 0  
3.814 
0.006 
635.7 
0.613 
0.283 
2 .1  66  
0.297 
0.410 
0.725 
2.180 
1 .246 
1.750 
1.979 
1 .103 
1.794 
6.791 
0 . 1 2 8  
53.05 
3-II 
active=r 2.006 0.262 1.834 4.102 
control=l 1.868 0.118 1.522 3.508 
ratio (a/c) 1 .074 2.220 1 .205 1 .169 
4.208 
5.584 
0.754 
5.240 
5.564 
0.942 
5-III 
active=l 1.927 0.804 1.628 4.359 
control=r 2.148 0.330 1.594 4.072 
ratio (a/c) 0.897 2.436 1.021 1.070 
7-1 
active=r 7.928 0.128 1.131 9.187 
control=l 4.079 0.876 1.184 6.139 
ratio (a/c) 1.944 0.146 0.955 1.446 
7-III 
active=l 1.441 0.262 0.564 2.267 
control=r 9.818 0.722 1.286 11.826 
ratio (a/c) 0.147 0.363 0.439 0.192 
1 .639 
1 .314 
0.755 
0.835 
1 .157 
1.491 
0.654 
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TABLE 17 (Continued) 
New bone New bone 
Rabbit external inside 
femur to Implant implant 
(r=right (mmZ) (mmZ) 
l=left) 
ratio 
(active/control) 
New bone Total 
inside new bone assr 
medullary (mmZ) Activation 
canal ratio 
(mmZ) 
1 0 - 1  
active=r 6.952 0.884 0.720 8.556 
control=l 4.155 0.516 0.227 4.898 
ratio (a/c) 1 .673 1 .713 3.712 1 .747 1.545 
10-11 
active=r 2.115 1.503 1.149 4.767 
control=l 1.316 0.811 1.048 3.175 
ratio (a/c) 1 .607 1 .853 1.096 1 .501 1 .449 
14-11 
active=r 1.901 0.508 0.085 2.494 
control=l 2.273 0.646 0.436 3.359 
ratio (a/c) 0.836 0.786 0.195 0.742 1.037 
14-III 
active=l 7.127 0.307 0.050 7.483 
control=r 2.965 0.407 0.294 3.666 
ratio (a/c) 2.404 0.754 0.168 2.041 1.418 
56-1 
active=r 0.0 1.532 1.116 2.748 
control=l 0.0 1.560 0.0 1.560 
ratio (a/c) 0.082 1 .697 1 .064 
56-11 
active=r 0.0 1.529 0.0 1.529 
control=l 0.0 1.184 0.0 1.184 
ratio (a/c) 1.291 1 .774 0.967 
area of periosteal new bone seen in the cross sections would 
indicate that the cross sections examined are fairly 
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TABLE 18. Correlations of the HOP-llI measurements with the 
strontium-85 activation ratios for the proximal 
segments of the implant series 
External Inside 
to implant implant 
Inside Total 
medullary new bone 
canal 
r = 0.898 0.131 0.222 0.825 
95X C.I. = (0.60,0.95) (-.5,+ .5) (-.55,+ .55) (0.48,0.94) 
99% C.I. = (0.45,0.98) (0.30.0.98) 
r2 = 0.806 0.017 0.049 0.681 
representative of the amount of new bone growth seen. 
Image analysis data from the distal segments of the 
implant series. Tables 20 and 21, showed low correlation 
with the strontium tracer data (r = 0.345, 95X C.I. = -.31 
to +.72). The Quantimet®data which measured the amount of 
bone ingrowth into the implants from the distal segments, 
showed no significant correlation (r = -.13). 
The Quantimet®data from the implants stained by 
Lillie's silver impregnation technique are shown in Table 
22. The strontium-85 data give a good measure of the total 
amount of new bone formed in a certain bulk volume of 
sample. The Quantimet®system can measure the area of bone 
in a given cross section with a high degree of accuracy. In 
general, the strontium tracer is the better method to 
analyze the bulk samples, while the Quantimet system is the 
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TABLE 19. Areas of new cancellous bone measured with the 
MOP-III electronic planiaeter in the implant 
series, midsegments (H and E stain) 
Rabbit Area of new o^Sr activation 
femur cancellous bone ratio 
(l=left (mm2) (counts active - bkg)/ 
r=right) (counts control - bkg) 
ratio (active/control) 
1-III 
active=l 1 .52 
control=r 0.33 
ratio (a/c) 4.61 1.614 
3-II 
active=r 2.27 
control=l 3.37 
ratio (a/c) 0.674 1 .096 
3-III 
active=l 2.22 
control=r 4.34 
ratio (a/c) 0.512 0.718 
5-1 
active=r 6.17 
control=l 8.15 
ratio (a/c) 0.757 0.777 
5-III 
active=l 4.66 
control=r 2.97 
ratio (a/c) 1.57 1.514 
7-1 
active=r 11.23 
control=l 3.09 
ratio (a/c) 3 .63 1 .740 
7-III 
active=r 6.18 
control=l 9.08 
ratio (a/c) 0.681 0.812 
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TABLE 19 (Continued) 
Rabbit Area of new sssr activation 
femur cancellous bone ratio 
(l=left (mmZ) (counts active - bkg)/ 
r=right) (counts control - bkg) 
ratio (active/control) 
10-1 
active=r 12.84 
control=l 7.70 
ratio (a/c) 1 .668 1 .132 
10-11  
active=r 1.66 
control=l 0.0 
ratio (a/c) 1.102 
14-11 
active=r 2.02 
control=l 0.0 
ratio (a/c) 0.881 
14=111 
active=l 12.14 
control=r 1.10 
ratio (a/c) 11 .04 1 .371 
56-1 
active=r 0.0 
control=l 0.0 
ratio (a/c) 
56-11 
active=r 0.0 
control=l 0.0 
ratio (a/c) 
r = 0.852 
99% C.I.= (0.05,0.99) n = 8 
r2 = 0.726 
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better method to measure the area of ingrowth in a given 
cross section. Table 22 shows both the actual area of bone 
measured by the Quantimet® system, and the percentage of the 
implant filled by this bone. These data show essentially no 
correlation with either the strontium tracer data or with 
the samples that were treated with PAA. 
Although the Quantimet® data failed to show a 
consistent correlation with the strontium tracer data and 
with the experimental femurs, the data did show a 
relationship with time. The average percent of the implant 
filled with bone increased from about 1.5% at day one to 
about 13.5% at day 56. This increase with time occurred for 
both the control and experimental femurs. 
Special Stains 
Transverse sections from the initial surviving rabbit 
of day seven from the endosteal activation series were 
examined with five different special stains. In this 
rabbit, the activated femur showed both endosteal and 
periosteal new bone growth, while the control femur showed 
no cancellous new bone growth either along the periosteum or 
the endosteum. Samples from this rabbit were chosen to 
illustrate the differences between a femur that had been 
activated and a contrateral femur that was not activated. 
This is the lone rabbit that survived an endosteal 
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TABLE 20. Areas of new cancellous bone measured with ^ e 
MOP-III electronic planimeter and Quantimet® 
image analysis computer in the implant series, 
distal segments (Lillie's silver Impregnation 
technique) . 
New bone New bone New bone Total 
Rabbit external inside inside new bone 85sr 
femur to implant medullary implant (mm^) Activation 
(r=right (mmZ) canal (Quantimet® ratio 
l=left) (mm2) data, mmZ) 
ratio 
(active/control) 
1-III 
active=l 0.638 0.0 0.182 0.820 
control=r 0.134 2.008 0.204 0.338 
ratio (a/c) 4.762 0.0 0.890 2.424 1.083 
3-II 
active=r 0.826 1.311 0.147 2.284 
control=l 0.428 0.971 0.374 1.773 
ratio (a/c) 1.930 1.350 0.393 1.229 1.095 
3-III 
active=l 0.729 1.291 0.336 2.356 
control=r 1.465 0.614 0.388 2.467 
ratio (a/c) 0.498 2.103 0.866 0.955 0.921 
5-1 
active=r 2.495 1.359 0.474 4.328 
control=r 3.613 0.418 0.084 4.115 
ratio (a/c) 0.691 3.251 5.643 1.052 0.837 
5-III 
active=l 1.350 0.689 0.318 2.357 
control=r 3.181 0.297 0.377 3.855 
ratio (a/c) 0.424 2.320 0.844 0.611 0.839 
7-1 
active=r 2.574 3.045 0.937 6.556 
control=l 1.773 0.615 1.009 3.400 
ratio (a/c) 1.452 4.951 0.929 1.930 1.153 
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TABLE 20 (Continued) 
New bone New bone New bone Total 
Rabbit external inside inside new bone ^^Sr 
femur to implant medullary implant ^(dd^) Activation 
(r=right (mmZ) canal (Quantime-frB) ratio 
l=left) (mmZ) data, mmZ) 
ratio 
(active/control) 
7-III 
active=l 4.286 
control=r 3.238 
ratio (a/c) 1.324 
1 0 - 1  
active=r 1.699 
control=l 13.054 
ratio (a/c) 0.130 
0.665 
1.323 
0.503 
0.623 
1 .084 
0.574 
0.585 
0.400 
1 .463 
0.740 
0.763 
0.970 
5.536 
4.961 
1 .116 
3.062 
14.901 
0.205 
1 .160 
0.555 
10-11 
active=r 0.706 0.943 1.260 2.909 
control=l 0.392 0.278 0.532 1.202 
ratio (a/c) 1.801 3.392 2.368 2.420 1.279 
14-11 
active=r 1.437 0.455 0.839 
control=l 1.371 0.651 0.634 
ratio (a/c) 1.049 0.699 1.323 
2.731 
2.655 
1.029 0.646 
14-III 
active=l 2.245 0.192 0.712 3.149 
control=r 3.135 0.620 0.839 4.594 
ratio (a/c) 0.716 0.310 0.849 0.685 1.684 
56-1 
active=r 
control=l 
ratio (a/c) 
0 . 0  
0 . 0  
0 . 0  
0.833 
0 . 0  
1 .005 
1.907 
0.527 
1.005 
2.740 
0.367 1 .070 
56-11 
active=r 0.0 
control=l 0.394 
ratio (a/c) 0.0 
0.400 
0 . 0  
1.150 1.550 
1.832 2.226 
0.628 0.696 0.872 
139 
TABLE 21> Correlations of the MOP-III measurements with the 
strontium-85 activation ratios for the distal 
segments of the implant series 
New bone 
external 
to implant 
r = 0.435 
95% C.I.= (-.27,+ .82) 
r2 = 0.189 
n = 10 
New bone 
inside 
medullary 
canal 
0.071 
0.005 
10 
New bone 
inside 
implant ^ 
(QuantimerS^ 
data) 
Total 
new bone 
-0.125 
0 . 0 1 6  
13 
0.345 
(-.25,+.75) 
0.119 
13 
(excludes 1-III, 56-1, and 56-11) 
application of 300 mg PAA per kg of body weight without 
first having any medullary tissue aspirated. The 
description of the following observations is all from this 
one rabbit. Stained cross sections from the femurs of this 
rabbit are shown in Figures 23, 24, 25, and 26. 
(£ÀS) siaia 
This blue stain. Figure 23, was a deeper blue in both 
the endosteal and periosteal areas of new bone growth. The 
areas of old bone and the bone from the control femur were 
less deeply stained. The cement lines were particularly 
distinct, indicating, perhaps, the incorporation of 
carbohydrates into the cement lines. Areas around spaces in 
the bone that did not seem to have bone forming activity 
were less intensely stained than the more active areas. 
1U0 
TABLE 22. Quantlmet®Image analysis data for ingrowth of 
bone into porous implants 
Days-rabbit # Area of Percent of ssgr Activation 
femur bone implant ratio 
(l=left (mm2) filled with 
r = right) bone 
1-III 1.083 
active=l 0.181 1.190 
control=r 0.203 1.662 
3-II 1.095 
active=r 0.167 1.020 
control:! 0.312 3,324 
3-III 0.921 
active=l 0.334 2.391 
control=r 0.386 3.143 
5-1 0.837 
active=r 0.471 3.105 
control=l 0.083 1.665 
5-III 0.839 
activ9=l 0.316 2.490 
control=r 0.375 4.109 
7-1 1.153 
active=r 0.931 5.88 
control=l 1.003 8.831 
7-III 1.160 
active=l 0.582 3.668 
control=r 0.397 3.182 
10-1 0.555 
active=r 0.735 4.813 
control=l 0.758 4.863 
10-11 1.279 
active=r 1.253 14.822 
control=l 0.529 5.871 
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TABLE 22 (Continued) 
Days-rabbit # Area of Percent of asgr Activation 
femur bone implant ratio 
(l=left (mmZ) filled with 
r=right) bone 
14-11 0.647 
active=r 0.834 8.840 
control=l 0.630 5.597 
14-III 1.684 
active=l 0.708 6.165 
control=r 0.834 8.840 
56-1 1.070 
active=r 0.999 11.760 
control=l 1.896 16.424 
56-11 0.680 
active=r 1.143 12.136 
control=l 1.821 15.277 
indicating that the bone forming areas were utilizing or 
acquiring more carbohydrates. 
Gomori^s £etiçulin Staia 
In this pink stain, the endosteal new bone was stained 
no darker than the older cortical bone. In some areas, the 
periosteal new bone was a little more darkly stained. 
Osteoblastic cells were stained brown. The lamella of the 
bone was well illustrated by this stain. Reticulin fibers 
were seen only in the medullary tissue. 
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FIGURE 23. Section from the experimental femur of the 
rabbit that survived an endosteal application of 
PAA of 300 mg/kg (PAS) 
Aleian Blue at eH 1.0 
This stained the bone a very faint blue. Figure 23. 
The faintness of the stain is probably indicative of the low 
concentration of sulfated glycoaminoglycans that occurs in 
mature bone. But, there were areas of interest that were 
more deeply stained. The periosteal cement line was made 
very distinct by this stain. Both the periosteal and 
endosteal new bone were stained slightly more than the 
mature cortical bone. Some of the spaces or cavities in the 
bone were filled with a featureless substance that was 
deeply stained. The surrounding soft tissue, muscle, and 
the medullary tissue were left completely unstained. 
FIGURE 2a. Section from the experimental femur of the 
rabbit that survived an endostal injection of 
PAA of 300 mg/kg (Alcian blue, pH 1.0) 
Aleian glue at gH 2.5 
This stain is selective for glycoaminoglycans in 
general. The pattern of staining with this stain was 
virtually identical to that of Alcian blue at pH.1.0. The 
only difference was that the stain at pH 2.5 was overall a 
fainter blue than the stain at pH 1.0. Glycoaminoglycans, 
GAG, (formerly referred to as mucopolysaccharides) are a 
basic component of the ground substance of connective 
tissues. They fill the spaces between the cells and the 
fibers in connective tissue. Nutrients that feed the 
connective tissue cells are soluble in the GAGs. Their 
presence in the bone, and their enhanced presence in new 
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FIGURE 25. Section from the experimental femur of the 
rabbit that suvived an endosteal injection of 
PAA of 300 mg/kg (Lillie's silver) 
bone and cement lines shown by these slides, is a normal 
phenomenon. 
Masson's Trichrome Stain 
With this stain, bone was stained in alternating red 
and blue stripes. The mature cortical bone was stained 
predominately red with thin blue stripes. At a 
magnification of 100, the new periosteal and new endosteal 
bone appear to be solid blue, but at a magnification of WOO, 
small stripes and spots of red were seen in the blue area. 
No distinct cement line was discerned. The cells of the 
medullary tissue were very dark, nearly black. The 
periosteum was dark brown and blue. The muscle bundles were 
1U5 
FIGURE 26. Section from the control femur of the rabbit 
that survived an endoseal injection of PAA of 
300 mq/kg (Lillie's silver) 
red, and the fibrous soft tissue was purple or blue. 
Summary of Sfiecial Stains 
Very little new information was found with these stains 
that could not be obtained with the H and E stain. 
Therefore, it was decided not to stain any other samples 
with these special stains. 
Microscopic Examination 
The periosteum of the rabbit, as in the rat, is 
composed of two layers, an outer fibrous layer and an inner 
cambium layer. The fibrous layer is composed of thick, 
flattened, spindle-shaped cells imbedded in stromal fibers 
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that run in a circumferential direction. In the resting 
periosteum, this layer is about two to four cells deep. The 
cambium layer is composed of plump basophilic round cells. 
The matrix of the cambium layer does not have the regular 
circumferential packing of the fibrous layer. The cells of 
the fibrous layer tend to be closely packed, while the cells 
of the cambium layer are loosely packed. With hematoxylin 
and eosin stain, the cambium layer is more basophilic or 
blue, while the fibrous layer stains more eosinophilic or 
red-pink. 
Over an area of active periosteal new bone formation, 
the cambium layer of the periosteum thickened from just one 
or two cellular layers to perhaps a dozen. Mitotic figures, 
or dividing cells, were seen on the plump cells of the 
cambium layer. A layer of polygonal-shaped cells lined the 
spicules of new bone being formed. These spicules tended to 
radiate outward perpendicular to the surface of the old 
cortex. The fibrous layer of the periosteum thickened and 
dispersed as the periosteum approached a callus. At the 
callus, the fibrous layer of the periosteum blended into the 
irregular fibrous connective tissue covering the callus. 
Near the callus, the cambium layer gradually merged into 
cartilage cells or into a loose fibrous connective tissue 
that merged into areas of cartilage and new cancellous bone. 
This anatomical description of a callus formation was 
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typically observed in both control and experimental femurs. 
It is, basically, normal bone callus formation and bone 
repair. 
Emfiti Defect Series, Proximal Seaments 
The microscopic slides from the proximal segments were 
all taken from transverse sections made through the 
approximate center of the defect or the implant. They were 
all stained with hematoxylin and eosin. 
Dai 1, one dai after administration of PAA and 8 dais 
after surgery Callus formation was present on the 
outside of the cortex in both the experimental femurs and 
the controls. The calluses were composed of cancellous 
bone, cartilage, and fibrous connective tissue. The new 
cancellous bone extended radially out of the matrix of the 
cortex. On top of the cancellous bone, and merging with it, 
there often were one or more masses of ossifying cartilage. 
The cartilage callus was covered by a layer of loose to 
moderately dense fibrous connective tissue. At day one, the 
cancellous new bone growth had just begun the process of 
bridging the defect. 
In addition to periosteal new bone growth, both the 
control and experimental samples presented cancellous new 
bone growth originating from the endosteum. Spicules of 
endosteal new bone were covered with osteoblastic cells. 
The spicules of endosteal new bone merged with the 
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cancellous new bone growth originating from the defect. The 
new bone growth from the defect merged with the cancellous 
new bone from the periosteum, forming a continuous matrix of 
cancellous bone covering much of the outside of the femur 
and wrapping around the cut edges of the defect and into the 
medullary canal. Adjacent to the defect, a small area of 
necrotic acellular cortical bone was undergoing resorption. 
This was bone that was injured by the creation of the 
defect. 
Day 3 As early as 3 days after the application of 
PAA (10 days after surgery), the growth of new cancellous 
bone completely bridged the gap in the cortex in one of the 
control samples. 
Dai 5 At the day 5 period, both the control and 
experimental samples displayed complete bridging of the 
defect wih cancellous bone at the level of the cortex. 
Histologically, the same features were noted in both 
the control and activated samples. Both control and 
experimental samples presented calluses composed of 
cancellous bone, cartilage, and fibrous connective tissue. 
In a day 5 control, cartilage callus covered the defect area 
over a bridge of cancellous bone. Both control and 
experimental samples showed resorption of necrotic bone, and 
both presented endosteal and periosteal new bone growth. 
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Day 2 At seven days, the spicules of new periosteal 
cancellous bone were broadening» In some places, the spaces 
between the spicules were completely filled with new bone, 
transforming the cancellous bone Into compacted cancellous 
bone. At 10 days, very few cells of cartilage were seen. 
The cartilage cells that were left were largely mineralized. 
At 7 days, one control sample showed the cortical defect to 
be only half bridged by cancellous bone projecting from both 
sides of the cut defect. In all the other samples at 7 and 
10 days, this gap was completely or almost completely 
bridged by cancellous bone. In some samples, the two fronts 
of cancellous bone growing out from the sides of the 
cortical defect are separated by only a narrow space of 
highly vascularized loose areolar connective tissue. 
Day 10 Even at 10 days, acellular necrotic bone 
tissue remained along the old cut edges of the defect, but 
more extensive replacement of this necrotic tissue was seen 
than at earlier time periods. At 10 days, the first 
definite examples of Haversian systems or secondary osteons 
were seen in new bone that replaced necrotic bone. In many 
textbooks, the Haversian system or secondary osteon is 
unfortunately described as if it was the typical or only 
type of bone. In rats and rabbits. Haversian systems are 
found only at sites of bone repair. The typical bone in the 
cortex of the rabbit's femur is composed of primary osteons. 
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The primary osteons in the rabbit are composed of several 
layers of lamellae around a central blood vessel. The 
contours of the outer layers blend into the contours of the 
interstitial bone that lies between the osteons. The 
secondary osteon results when a resorption cavity is formed 
in the bone. The resorption cavity is then filled by 
concentric lamellae of new bone until a single capillary 
remains in the center. A secondary osteon has a distinct 
cement line that outlines the border of the former 
resorption cavity. In the rabbit, osteons with a cement 
line were observed only in areas where necrotic bone tissue 
had been replaced by new bone. 
Day 14 Even at fourteen days, the gap in the 
control sample was not completely bridged by cancellous 
bone. In both control and experimental samples, most of the 
periosteal new bone was compacted cancellous bone. In the 
experimental sample, a large callus composed of cancellous 
bone and fibrous connective tissue still remained. No 
cartilage was seen in either the control or experimental 
samples. The periosteum still showed areas of activation 
where new bone formation was still occurring. The endosteal 
surfaces of the femurs did not display any spicules of new 
bone growth. 
Summary The active production of periosteal new 
bone as seen in Figures 27, 29, and 30 occurred at all time 
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periods examined from day 1 to day 14, and it occurred in 
both control and experimental femurs. The periosteal 
activation agent appeared to enhance the natural bone growth 
phenomenon that occurs in response to an injury. 
Endosteal new bone was present the day after 
application of PAA (8 days after surgery) , but it tended to 
disappear by day lU (21 days after surgery). Cartilage 
callus was present in most samples from day one through day 
seven. It was nearly all gone by day 10. Necrotic bone 
near the edge of the defect was present at all time periods, 
but showed signs of being partly replaced by day 10. 
Bridging of the defect occurred as early as day 3, but in 
some samples the defect remained partially open even at day 
11 as can be seen in Figure 27. Areas of cancellous 
periosteal new bone were converted into compacted cancellous 
bone as early as day 7. Compacted cancellous bone was 
common in samples at days 10 and lU. 
EËEtj Defect Series, Midseqments 
The H and E stained slides from the midsegments were 
transverse sections taken through a point near the center of 
the midsegments. Although the midsegments did not contain 
any defects or implants, they did display callus formation, 
activation of the periosteum, and some endosteal new bone 
growth. 
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Periosteal callus formation was seen in both the 
activated and control samples at all the time periods. At 
day 1 (0 days after surgery), the periosteal calluses were 
composed of large masses of cartilage that covered small 
areas of cancellous new bone. The cartilage masses were 
covered by loose areolar connective tissue. At day 3 the 
calluses in the activated sample displayed large areas of 
cartilage, while the control sample showed very little 
cartilage. The periosteal calluses were composed of 
cancellous bone. At day 1, the periosteal callus from one 
rabbit was mostly compacted cancellous bone in both the 
control and experimental samples. The samples examined from 
the other rabbit from day 7 displayed large periosteal 
masses of both cartilage and cancellous bone. In the 
activated sample from this day 7 rabbit, there was a layer 
of cancellous new bone covering a mass of cartilage. The 
cartilage was actually sandwiched between two layers of 
cancellous bone. In the day 10 and day 14 samples, very 
little cartilage was seen. What cartilage was seen was 
usually in the final stages of mineralization and necrosis 
of chondrocytes. At these longer time periods, the 
periosteal calluses were composed of bone that was largely 
cancellous at the thick part of the callus and compacted at 
the thinner parts. It seemed that conversion of the 
cancellous bone into compacted cancellous bone originated 
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near the old cortex, and perhaps never reached the outermost 
points of the callus. In the long-term 56 day samples, the 
callus lumps were gone, evidently having been resorbed. 
A few spicules of endosteal new bone surrounded by 
osteoblastic cells were seen in both the activated and the 
control day 1 samples, the activated day 3 sample, the 
activated day 5 sample, and the control day 10 samples. 
Curiously, an extensive amount of active endosteal new bone 
was observed in the experimental day 14 sample. 
Im2lant Series, Proximal Sec[ments 
In the proximal segments of the implant series, the 
events in the progression of the calluses formed around the 
outside of the cortex were essentially the same as in the 
proximal segments of the ED series. In the implant series, 
the implants tended to project slightly above the periosteal 
level of the cortex by appproximately 0.5 am. 
1, one aai aftef ajgEliçatign of fAA but eight da^s 
after surgery The activated sample showed considerably 
more new bone growth than the control. Large areas of both 
endosteal and periosteal new bone were present in the 
activated sample. Spicules of endosteal new bone occurred 
whenever the contours of the implant brought it near the 
endosteum. The interstices of both implants were filled 
with a loose areolar connective tissue that contained 
stellate cells, long flat spindle-shaped cells, and round 
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cells. In the control sample, the implant was capped by two 
layers of tissue. The first layer above the implant was an 
irregular fibrous connective tissue, and the second layer 
was a loose areolar connective tissue. There was no bone 
ingrowth into the interstices of the control implant, and 
there was very little ingrowth into the experimental 
implant. 
Day 3 Some osteoid ingrowth in the interstices of 
the implants were present in the experimental and the 
control samples as can be seen in Figures 29 and 30. The 
limited ingrowth occurred where the implant interfaced with 
the cortex of the femur and where the base of the implant 
contacted or came near the endosteum. Large amounts of 
cartilage callus were present around the outside of the 
cortex. 
The interstices of the implant were filled with a loose 
areolar connective tissue that contained round cells, red 
blood cells, flat spindle-shaped cells, and some stellate 
cells. 
Day 5 These samples showed much more osteoid and 
bone inside the interstices of the implant than the 3 day 
samples. The ingrowth was confined to the region of the 
implant in contact with the cortex and where the implant 
came within about 0.5 mm to the endosteum. The sample from 
one rabbit in this time period presented a small medullary 
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FIGURE 27, Section from a control femur from the empty 
defect series at day It (H and E). 
FIGURE 28. Section from the experimental femur from the 
implant series at day 56 (H and E). 
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FIGURE 29. Section from an experimental femor from the 
implant series at day 3 (H and E). 
FIGURE 30. Section from the contralateral control femur 
from the rabbit in Figure 29 (H and E). 
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canal that was nearly filled by the Implant in both the 
control and experimental femurs. In this animal, bone 
ingrowth was present all along the sides of the implant. 
The implants were covered with a loose connective 
tissue, and the interstices of the implant were filled with 
the same type of tissue. Spindle-shaped cells, round cells, 
and some stellate cells, as are common to a loose areolar 
connective tissue, were seen in the interstices. The round 
cells are probably lymphocytes and the spindle-shaped cells 
are probably fiberblasts which form bundles of collagen 
fibers. The stellate cells are probably mesenchymal cells 
that extrude ground substance and a delicate network of 
collagenous fibers. 
Some of the periosteal new bone formed in the calluses 
around the cortex displayed areas of compacted cancellous 
bone • 
Day 2 The implants showed extensive Ingrowth of new 
bone. The bone ingrowth was most extensive where the 
implant contacted the cortex. In some samples, the ingrowth 
of new bone coming in from opposite sides of the implant met 
and formed a bridge of bone spicules crossing the implant at 
the level of the cortex. 
The interstices of the implant that were not filled 
with bone were filled with a loose areolar connective tissue 
similar to what was seen at earlier time periods. However, 
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at the cortical level of the implant and near areas of bone 
ingrowth, the fibers of the interstitial tissue were denser 
and resembled unmineralized osteoid to varying degrees. 
The samples all displayed extensive calluses around the 
outside of the cortex. In one control sample, there was 
extensive callus formation composed of cancellous bone, 
cartilage, and loose connective tissue. Some of the 
periosteal and endosteal new bone was compacted cancellous 
bone. Some compacted periosteal new bone was seen in all of 
the seven day samples. In two control samples, some 
periosteal new bone was seen growing over the top corner of 
the implant. In one sample, this bony overgrowth occurred 
even though the implant appeared to have originally extended 
slightly above the level of the original cortex. 
Day 10 The samples tended to display a continuation 
of the processes occurring at the early time periods. In 
two samples (one control and one experimental), the front of 
bone ingrowth bridged the implant at the cortical level. In 
the other two samples (one control and one experimental), 
the bone ingrowth from opposite sides of the implant did not 
quite meet. Spicules of endosteal new bone were often seen 
lining the sides of the implant. The loose areolar 
connective tissue that filled the interstices of the implant 
was more dense near the areas of bone ingrowth. A little 
more of this denser connective tissue seemed to be present 
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in the day 7 samples. There also seemed to be more 
compacted cancellous bone in the periosteal calluses on the 
outside surface of the femur. 
Replacement of necrotic bone was observed in the cortex 
adjacent to the defect. The pattern of resorption of 
necrotic bone, and subsequent replacement with new bone 
containing secondary osteons, occurred in about the same 
time period as in the endosteal defect series. 
Day 14 Even a wait of 21 days after surgery did not 
insure that bone ingrowth would completely infiltrate across 
the implant. In the samples from one day 14 rabbit, there 
was not complete bridging of the implant in either the 
control or the experimental sample. Only a modest amount of 
ingrowth was observed in either sample. The samples from 
the other rabbit displayed complete bridging in both the 
experimental and the control samples. In the later samples, 
the bridging occurred at the endosteal level, across the 
lower part of the cortex. Bone ingrowth did not extend to 
the top center of the implant. Some ingrowth was observed 
where the base of the implant contacted the endosteum, and 
this was observed in both control and experimental implants. 
In one experimental sample, ingrowth was observed along one 
entire side of the implant. 
The soft tissue infiltrating the implant was a loose to 
moderately dense connective tissue that contained primarily 
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flattened spindle-shaped cells and a few stellate cells. 
The external calluses were comprised mostly of 
compacted cancellous bone in all of the day 14 samples. One 
control sample displayed a particularly large callus. In 
one experimental sample, the compacted periosteal new bone 
covered one corner of the implant. 
Resorption of necrotic bone was observed in the cortex 
adjacent to the implant in both control and experimental 
samples. 
Day 56 The long-term implants displayed the 
greatest amount of bone ingrowth. Figure 28. In the earlier 
time periods, the ingrowth tended to be narrow spicules that 
did not completely fill the interstices they entered. In 
the long-term samples, the spicules of ingrowth were broad, 
spanning the complete diameter of the openings they entered. 
As in the short term samples, the ingrowth occurred mostly 
at the cortical level of the implant. The ingrowth seemed 
to serve as replacement of the cortex that had been removed. 
The ingrowth was most intense at the endosteal level of the 
implant, it never extended to the central axis at the top of 
the implant. Beneath the level of the cortex, there was 
scattered bone ingrowth in the implant. In the medullary 
canal, but outside of the implant, there were no spicules of 
endosteal new bone in any of the day 56 implants. 
The soft tissue that infiltrated the implant was a 
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loose areolar connective tissue. It contained mostly red 
blood cells and darkly stained round cells and only a few 
flattened spindle-shaped cells. It closely resembled 
regular hematopoietic tissue. 
The periosteal new bone was completely compacted in all 
the samples. The periosteum had returned to its normal 
resting state. The fibrous layer of the periosteum was only 
a few cells deep, and the cambium layer was just one or two 
cells deep. In some places, the cambium layer seemed to 
have been reduced to one layer of widely separated cells. 
In one control sample and in one activated sample, the new 
periosteal bone formed a solid cap over about half of the 
top of the implant. In one control sample, the periosteal 
new bone completely covered the top of the implant. 
Even at 63 days after surgery, some necrotic bone 
remained near the implant in all of the samples examined. 
Some of the necrotic bone was being resorbed; much of it had 
already been replaced with a bone matrix rich in secondary 
osteons. 
Summary Bone growth into the implants was present 
as early as 8 days after surgery and one day after the 
application of PAA. The ingrowth originated where the 
implant came in contact with the cortex, and also where the 
edges of the implant contacted bone tissue or came within 
about 0.5 mm to the endosteum. By day 7 (1U days after 
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surgery), there were samples where the bone ingrowth from 
the cortex had penetrated to the center of the implant, 
forming a bony bridge through the implant at the level of 
the cortex. The rate that bone ingrowth occurred at was 
highly variable. Even at day lU (21 days after surgery) 
there were samples where the ingrowth had not penetrated to 
the center. The samples that had received the application 
of FAA did not consistently show any more rapid ingrowth 
than did the control samples. By day 56, the samples all 
showed thick spicules of bone ingrowth filling the 
interstices of the implant at the level of the cortex. In 
the medullary level of the implant, there were scattered 
spicules of bone. 
During the early stages of bone Ingrowth, there was an 
activation of the endosteum wherever the implant came in 
contact with the endosteum, or came very close to the 
endosteum. At day 1 and day 3, there was a considerable 
amount of new bone spicules emerging from the endosteum and 
almost appearing to reach for the implant. Spicules of bone 
were seen lining the sides of the implant as late as day 10. 
But at day 56, the spicules of medullary bone were all gone 
except for a few scattered spicules inside the implant. 
During this period, the soft tissue that filled the 
interstices of the implant gradually changed from a loose 
areolar connective tissue that contained mostly stellate 
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cells, long, flat spindle-shaped cells and some round cells 
to either bone or normal hematopoietic tissue. 
The changes observed on the periosteal surface of the 
bone during this time period were essentially the same as 
that seen in the empty defect series. Calluses that were 
composed of cancellous new bone, cartilage, and fibrous 
connective tissue at the early time periods were gradually 
converted to compacted bone. 
seflsg, aiAssaamats 
The H and E stained slides from the midsegments were 
transverse sections taken through a point near the center of 
the midsegments. Although the midsegments did not contain 
any defects or implants, they did display callus formation, 
activation of the periosteum, and some endosteal new bone 
growth. 
The time sequence of tissues from the midsegments 
observed in the implant series was very similar to that seen 
in the empty defect series. The calluses were observed to 
go through three overlapping stages of transformation. In 
the first stage, extensive cartilage calluses were seen in 
the day 1 through day 5 samples. In the second stage, these 
were largely replaced by cancellous bone in the day 5 
through day 1U samples. In the third stage, the spaces 
between the spicules of cancellous bone were filled to form 
compacted cancellous bone. As early as day 10, some of the 
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smaller callus formations were completely compacted 
cancellous bone. At day 56, all of the remaining calluses 
had been transformed into compacted cancellous bone. These 
stages overlapped. Cancellous bone was seen as early as day 
1 in both the control and activated samples, but more 
frequently in the activated samples. Residues of cartilage 
in its final stages of mineralization were seen as late as 
day 10 in both a control and an activated sample. 
Most of the samples from the midsegments of the implant 
series did not show any endosteal new bone. This was 
expected, since there was no hole drilled in the midsegment 
and the microscope slides from the midsegments were taken at 
a point midway between the implants. However, a few 
spicules of active endosteal new bone growth were observed 
in a control day 3 sample, an experimental day 5 sample, and 
both control day 5 samples. More extensive areas of 
endosteal new bone growth were observed in one experimental 
day 7 sample and one experimental day 14 sample. 
Endosteal Activation Series 
Transverse cross sections were made through the center 
of the proximal, mid, and distal segments and stained with 
hematoxylin and eosin. 
Initial Rabbit The decision to proceed with this 
series was prompted by the results from one rabbit that 
survived an endosteal injection of 300 mg of PAA per kg of 
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body weight. This injection was nade without first 
aspirating any medullary material. The rabbit was killed 7 
days after the application of PAA. Transverse cross 
sections were made from the proximal, mid, and distal 
segments from the femurs of this rabbit. Sections from the 
proximal and midsegments were stained with B & E, and the 
sections from the distal segments were stained with Lillie's 
silver impregnation technique. The control sections from 
this animal. Figure 26, all showed a normal appearing femur. 
There was no new bone formation in either the periosteum nor 
the endosteum. All the microscopic sections from the 
experimental femur showed areas of both periosteal and 
endosteal new bone formation (Figures 23 and 25). In the 
medullary canal, anastomosing spicules of bone were seen 
emerging from the endosteum. These spicules of bone were 
covered with darkly stained osteoblastic cells. Cancellous 
bone was seen partially ringing the periosteal surface of 
the cortex. This cancellous bone did not resemble a 
fracture callus. It contained no cartilage, and it was 
spread in an even, thin strip around the cortex. There was 
no single large lump of tissue as was seen in the cortical 
calluses of the other two series. 
ES5l Series In the rest of the endosteal 
activation series, greater survivability was achieved by (1) 
reducing the amount of PAA injected from 300 to 100 mg per 
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kg of body weight and by (2) aspirating an amount of 
medullary tissue and fluid equal to the volume being 
applied. In the rest of the series, both the radiation 
(Table 12) and the microscopic results were not as 
conclusive. Little endosteal new bone was seen in any of 
the day 1 samples examined or in any of the day 5 samples. 
One day 3 sample from an activated femur showed a single 
large spicule of endosteal new bone. The other sample was 
from a control femur, and it showed two broad fingers of 
bone covered with osteoblastic cells emerging from the 
endosteum (Figure 31). They appeared to encircle an area of 
the cortex that may have been pierced by one of the sharp 
surgical instruments used in this procedure. Spicules of 
endosteal bone covered with osteoblastic cells were often 
seen in both control and experimental samples at days 7 and 
10 (Figures 32, 33, and 34). 
In a rabbit at day 7 that gave a total femur activation 
ratio from the strontium tracer of 1.036, endosteal new bone 
was seen in all segments of both the control and the 
experimental femur. The endosteal new bone was fairly 
extensive in the proximal and distal segments from the 
experimental femur. Extensive areas of endosteal new bone 
were seen in all samples taken from the 10 day period. This 
was observed in both experimental and control samples. In 
one experimental section from the midsegment, about three 
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FIGURE 31. Sample from a control femur from the EA series 
at day 3 (H and E) 
FIGURE 32. Sample from a control femur from the EA series 
at day 7 (H and E) 
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FIGURE 33. Sample from an experimental femur from the EA 
series at day 10 (H and E) 
Sample from the contraleral control femur of the 
sample in the Figure 33 (H and E) 
FIGURE 34 
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quarters of the endosteum were covered with spicules of new 
bone lined with palisades of osteoblasts. 
The medullary canal in these samples showed signs of 
the damage done when a small hole was drilled through the 
trochanter fosse and when about 2 ml of medullary tissue and 
fluid was aspirated from each femur. Chips of necrotic bone 
were observed in samples as late as day 7. A clot of red 
blood cells was present in the medullary canal in all the 
day 1 and day 3 samples and one of the day 5 samples. The 
medullary canal in one experimental day 5 sample displayed a 
circular tissue-free area or hole about 1 mm in diameter. 
At day 3, polymorphonuclear leukocytes or white blood cells 
were observed in the medullary canal. By comparison, at day 
7 and day 10, a single large red blood cell clot was not 
observed in the medullary canal. In its place was an area 
of fairly acellular loose areolar connective tissue 
occupying one-third to one-half of the medullary canal and 
often containing scattered clumps of red blood cells. The 
rest of the medullary tissue was normal appearing 
hematopoietic tissue. 
The periosteum in these samples usually displayed some 
areas of new bone growth. In most of the samples, this 
appeared to be the normal new bone growth occurring by 
apposition of a layer of new primary osteons onto the outer 
rim of the cortex. A thickening of the cambium layer of the 
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periosteum with darkly stained polygonal-shaped cells lining 
the surface of the underlying bone was usually seen. The 
new bone would take the form of small lumps or ruffles on 
the surface of the old cortex. Trabeculae of cancellous new 
bone, as was observed in the calluses of the other series, 
was generally not present on the periosteum. 
Due to their wide variability, the results from the 
endosteal activation series. Table 12, were not as 
conclusive as we would have liked. The techniques that we 
used to apply the PAA or the control pyrogen-free saline, 
evidently stimulated endosteal new bone growth by itself. 
Prior to the PAA injection or the sham injection, a probe 
was first inserted down the medullary canal to make sure 
that the medullary canal had been located. Then a volume of 
medullary tissue and fluid equal to the volume of fluid to 
be injected (usually about 2 ml) was aspirated from the 
medullary canal. This aspiration of medullary tissue and 
fluid was performed upon advice that this could prevent 
embolism. Such embolism was considered to be a possible 
cause of the early failure of many of the first endosteal 
applications. However, microscopic examination showed that 
this technique injured the medullary canal. The large 
amount of endosteal new bone growth that was seen in both 
the control and experimental femurs 7 and 10 days after this 
assault on the medullary canal (Figures 32, 33, and 34) was 
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probably due to an Injury response or due to the physical 
stimulus to the endosteun from the instruments used. 
A graphic summary of the microscopic examination is 
presented in Figure 35. In this figure, the occurrence of 
certain features is noted. A solid line means the feature 
was seen in all, or almost all, samples examined in the time 
range given. A broken line indicates that the feature was 
seen in some of the samples examined in the given time 
range. The markings begin at the time when observations 
began. 
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FIGURE 35. Summary of microscopic examination showing 
certain tissues and events observed in the ED, 
I, and EA series 
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CONCLUSIONS 
This Study was not able to show that PAA encouraged 
bone growth into a porous implant or accelerated healing of 
a defect. What it did show, was that PAA significantly 
enhanced the amount of periosteal callus formation 
associated with an injury to the bone. This enhancement of 
periosteal callus formation began as early as one day after 
the application of PAA (p<.05), and continued for 14 days 
after its application. With the exception of endosteal new 
bone observed in some rabbits, the bone growth effects of 
this compound seemed to be confined exclusively to the 
periosteum• 
The mechanism of PAA remains unresolved. As described 
in the Literature Review, its effects may be due to a 
glycoprotein or biological interaction of a negatively 
charged chemical species, or to some type of morphogen that 
activates specific cells. To the best of our knowledge, no 
research has been undertaken in recent years to characterize 
either its chemical structure or its mechanism of action. 
The aspects of differentiation are described in the 
results section and discussed later in this section. 
Possible future applications based on our findings are 
discussed under Recommendations and Considerations for 
Future Research. 
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The potency values obtained from the preliminary trials 
on rats, rabbits, and puppies (Tables 2, 3, U, 5, and 6) 
showed that by following the procedure of patent 3,458,397 
(Myers et al. 1966) we were able to successfully extract a 
periosteal activation agent from cancellous bone. The last 
four batches of the extract prepared by us all seemed to 
have roughly the same potency; however, they were all much 
less potent than the agent used by Tornberg and Bassett 
(1977) . The phenomenon we observed in rats in response to 
the application of this extract did not seem to be any 
different from what they observed in rats. 
In larger animals, such as the rabbits and the puppy, 
PAA did not elicit a response as spectacular as it did in 
the rat. In the rat, potency values as high as 393 (Table 
2) were observed in response to 120 rag of PAA per kg of body 
weight. In the rabbit, 600 mg of PAA per kg of body weight 
had to be applied to produce a potency value of 235 (Table 
5). Such species differences may be due to the difference 
in surface area to volume in different bones (Table 7) . 
The periosteal activation agent used in this study 
apparently worked by promoting and enhancing normal 
endochondral ossification that occurs in the periosteum in 
response to an injury. Both the strontium-85 uptake data 
and the image analysis confirm that in the empty defect 
series, the samples that had received an application of PAA 
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experienced more new bone growth than the control samples. 
All 18 of the activated femurs in this series showed a 
greater total uptake of strontium than their respective 
contralateral controls. The odds against this happening by 
chance are 262,144 to 1. 
Some points about the strontium-85 data from the empty 
defect series are that they showed an enhancement of bone 
growth in the experimental femur that continued for at least 
14 days, and that they showed peaks at day 5 (p<.05) and day 
14. The continued enhanced bone growth at day 10 (p<0.05) 
and day 14 is interesting because the previous data 
published on PAA stated that new bone formation was 
completed in about 7 days in the rat (Tornberg and Bassett, 
1977). This longer term enhancement of bone growth is more 
consistent with studies done using demineralized bone powder 
to accelerate healing of defects in the rat mandible where 
the periosteum had been removed (Kaban and Glowacki, 1981). 
In that study, the uptake of calcium-45 reached its peak in 
14 days. Another study compared the osteogenic response of 
four different graft materials in the calvaria of 35 guinea 
pigs. It showed that the uptake of strontium-85 peaked at 
28 or 35 days for all four of the substances (Mellonig, et 
al. 1981). The four substances tested were freeze-dried 
allograft, .decalcified freeze-dried allograft, autogenous 
bone blend, and autogenous osseous coagulum. However, 
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autogenous bone blend and autogenous osseous coagulum showed 
an initial peak at day 14. There was no strontium-85 uptake 
peak in that study at day 5, and the researchers did not 
observe any particular phase change at day 14. 
The strontium uptake peak at day 5, does, however, fit 
in with the previously published data on PAA. Tornberg and 
Bassett (1977) reported that the mineralization phase of the 
periosteal activation response occurred from 60 hours to day 
7, with numerous areas of crystal formation being observed 
by 72 hours (3 days). It should be remembered that the 
strontium-85 uptake data is a measure of bone growth 
activity from the time the strontium was injected to the 
time the animal was killed, 24 hours later. 
Even as early as 1 day after the application of PAA, 
both the implant series and the empty defect series 
indicated an enhanced uptake of strontium in the 
experimental femur (p<.05 for both series). This is 
surprising since in the earlier work on PAA, mineralization 
was not observed until 60 hours after the application of PAA 
(Tornberg and Bassett, 1977). These differences (enhanced 
mineralization as early as day 1 and continuing at least 
through day 14) may be due to the different model used in 
this experiment. In the model used by Tornberg and Bassett 
(1977), the periosteal activation agent was applied to the 
resting periosteum of the midshaft region of 250 g mature 
177 
Sprague-Dawley rats. The bones in these rats were intact 
and were not undergoing fracture or defect repair. In the 
model used in this experiment, PAA was applied to the 
periosteum of rabbit femurs that were in the process of bone 
repair. The periosteum of these rabbits had already been 
activated by the defect surgery that occurred 7 days 
earlier. Microscopic examination of the 1 day samples did 
show large cartilage repair calluses which obviously had not 
formed "overnight". The application of PAA at this stage of 
repair served to further activate the periosteum to cause an 
almost immediate increase in the amount of mineralization. 
Placing an implant in the defect, as was done in the 
implant series, added complicating influences to the model. 
About one-third of the strontium uptake data from the 
implant series gave negative results where the control 
samples were more radioactive than the experimental samples. 
There are a few factors that may account for this. One 
possibility is that the implants applied and transmitted 
stresses to the bone that encouraged bone formation and bone 
resorption. It has been shown that living bone will respond 
to the stresses applied to it by forming new bone in areas 
of dynamic compression and by allowing old bone to be 
resorbed in areas of dynamic tension (Wolff, 1892; Bassett, 
1971). Another possible factor was revealed in the 
microscopic examination of the implant series. New bone 
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growth from the endosteum seemed to be elicited whenever the 
base of the implant came in contact with or came close to 
the endosteum. The physical contact of the implant with the 
endosteum may have elicited an activation of the endosteum. 
Slight differences in the precise location of the defect, in 
the angle that the defect hole was drilled, in the tightness 
of fit between the implant and the defect hole, in the size 
of the femur, and in how well the base of the implant 
abutted against the endosteum on the opposite side of the 
cortex would all influence the distribution and amount of 
new bone growth. Attempts were made to keep all these 
factors uniform. The location of the defect holes were 
carefully measured. The defect hole was always drilled in 
about the same location on the same side of the bone. An 
effort was made to hold the drill at the same angle when 
boring the hole. The implant was always cut to fit the hole 
drilled, so that the base of the implant abutted against the 
opposing endosteum and the top of the implant was flush, or 
almost flush, with the periosteal surface of the bone. The 
rabbits used were all of the same breed. New Zealand white, 
and they all came from the same breeder. The femurs from 
the smaller rabbits were generally a little smaller than the 
femurs from the larger rabbits, but there were no noticeable 
differences in size between the left and right femur of the 
same rabbit. In all of these steps, there were slight 
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differences that could not be avoided. The sum of all these 
differences may be responsible for the greater scatter of 
data in the implant series compared with the data from the 
empty defect series. 
The pore sizes of the implants were adequate for bone 
ingrowth. Previous workers have shown that an 
interconnecting pore size of 100 yc/m in diameter is 
sufficient in a biocompatible materials to permit bone 
ingrowth (Hulbert et al. 1970). The Biopore implants used 
in this study had an average pore size of 127 fxm diameter, 
and 89.5% of the pores were greater than or equal to 117 fim 
in diameter. The material the implants were constructed of 
was a high purity, medical grade, high density polyethylene. 
This material is currently used in orthopedic applications. 
It has been used successfully in a porous form as a matrix 
for bone ingrowth many times (Spector et al. 1976, Klawitter 
et al. 1976, Spector et al. 1979). Microscopic examination 
of these porous plugs after they had been implanted, showed 
the surface openings of pores were not damaged by the 
implantation procedure. Short penetrations of bone ingrowth 
(approximately 0.1 to 0.2 mm) was observed at the edges of 
the implant as early as eight days after surgery. 
The amount of new bone seen on the samples stained with 
H & E correlated with the strontium uptake data moderately 
well for the empty defect series (r=0.U7, 9555 C. I.=-.OU to 
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+.85 for proximal segments; r=0.66, 95X C. I.=-.17 to +.92 
for nld segments) and very well for the implant series 
(r=0.825, 99% C. I.=.30 to .98 for the proximal segments; 
r=0.852, 95% C. I.=.25 to .94 for the mid segments). Close 
examination of the components of these data showed that 
these correlations were due almost entirely to the large 
masses of periosteal new bone formed on the outer 
circumference of the femurs (which was enhanced by PAA). 
There was not convincing evidence that the application of 
PAA enhanced bone growth inside the defects or inside the 
medullary canal. The data from the Quantimet®image 
analysis computer, that was capable of measuring the area of 
bone ingrowth in a given cross section with a high degree of 
accuracy, also did not indicate that the amount of bone 
ingrowth had been influenced by periosteal application of 
PAA. These results indicate that the agent as applied in 
these experiments is almost exclusively a periosteal 
activation agent. It did very little or nothing to 
stimulate or accelerate bone growth outside of the 
periosteum or bone ingrowth into a porous high density 
polyethylene implant. This work thus establishes some 
possible limitations on the application of PAA. It also 
establishes that even when the periosteum has already been 
activated by an injury, PAA will enhance the amount of new 
bone formation during a time period of 1 to 10 or 14 days 
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after its application. 
In the proximal segments from the implant series (Table 
17), the fraction of the new bone that arose from the 
endosteum varied considerably, from a low of 0% in some of 
the day 56 samples and 0.7% in one day 14 sample to as high 
as 56.2% in day 1 sample. Generally, both the absolute 
amount of endosteal new bone measured in mia^ and the percent 
of the total new bone that came from the endosteum was 
larger in the shorter term samples from days 1,3, and 5 
than in the longer term samples from days 7, 10, 11, and 56. 
This may indicate that the endosteal new bone, whether it is 
due to PAA or to surgical trauma, is formed earlier and is 
resorbed sooner. 
In the initial rabbit that survived the endosteal 
application of 300 mg of PAA per kg of body weight 
(treatment without first aspirating medullary material), 
there was no activation of the endosteum seen in any of the 
control cross sections. The experimental cross sections all 
showed activated areas of the endosteum (Figure 23) at 7 
days. Not only was the endosteum activated in the 
experimental femur from this rabbit, but the periosteum also 
showed new bone growth. No periosteal new bone was seen in 
the control samples. In this one rabbit, it seems that a 
large endosteal application of PAA may have stimulated new 
bone growth at both the endosteum and periosteum. Perhaps 
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the force of injecting the PAA into the medullary canal was 
strong enough to force it into the blood supply where it was 
carried to the outside of the bone. Or perhaps, from this 
large amount of PAA injected, enough was able to ooze out of 
openings in the bone to stimulate the periosteum. 
The injury response is probably largely responsible for 
the wide scatter of the strontium data from the other 
rabbits of the endosteal activation series. It may also be 
responsible for the large amount of "negative" data from 
this series where the control samples were more radioactive 
(sometimes nearly twice as radioactive) than the 
experimental samples. Most of this negative data occurred 
at the early time periods (day 1 and day 3). The later time 
periods (days 5, 7, and 10) gave largely positive strontium 
uptake data for the total femur. Due to the high 
variability in the data, it is difficult to tell if this 
indicates a trend, or if it is just a random fluctuation. 
The observations of the 5 special stains (Gamori's 
reticulin, Alcian blue at pH 1.0 and 2.5, PAS, and Masson's 
trichrorae) did not reveal anything unusual about the 
periosteal and endosteal new bone observed in the samples 
examined. The samples examined with these stains were only 
ones that showed periosteal and endosteal new bone that may 
have been elicited by their treatment. Due to the expense 
involved, no extensive study was made of defect repair or 
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bone ingrowth using these stains. 
One question that will have to go unanswered is: in the 
absence of any other injury or endosteal stimulus, does PAA 
activate the cells of the endosteum to produce new bone? On 
the basis of data from just one rabbit, it appears that the 
answer to this question may be yes. For a definite answer 
to this, additional experiments need to be performed as 
follows: apply PAA to the endosteum of a series of animals 
with a minimum of assault to the endosteum and medullary 
canal and compare with controls from the contralateral 
limbs. 
It has been over four year since Tornberg and Bassett 
(1977) published their original paper on the effects of this 
substance which I have chosen to call periosteal activation 
agent. It has been well over a decade since Squibb 
Laboratory originally developed and patented this substance. 
In that time no one, to my knowledge, has established what 
the activation agent or agents are. There are a number of 
reasons that may explain why so little research has been 
done on PAA. Probably, the main reason why little research 
has been done on PAA is because of the expense that would be 
involved in getting government approval for its use in human 
medicine. It would have to be shown fairly conclusively 
that it does not cause unwanted bone growth or cancer. 
Another obvious reason is because there does not exist a 
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good commercial source of PAA. Squibb Laboratories stopped 
manufactoring PAA over a decade ago (R. C. Millonig, The 
Squibb Institute for Medical Research, Princeton, N. J. 
08540, personal communication) and all of their old supplies 
are gone. This researcher had to go through considerable 
effort to extract the agent from the ground ribs of calves. 
The agent used in this study is not as potent as the agent 
that was extracted at Squibb laboratory. Tornberg and 
Bassett (1977) used a batch of PAA that had been prepared at 
Squibb Laboratories some years earlier. They were able to 
elicit what they called an "explosive" subperiosteal 
osteogenesis by using 2.4 mg of agent per kg of body weight 
in the rat. To produce the same phenomenon, we had to use 
about 250 mg of PAA per kg of body weight in the rat. 
Another reason why so little research has been done on PAA 
may fae because those interested in bone stimulation have 
chosen to pursue other paths of achieving it. Urist et al. 
(1979a) has been trying to characterize bone morphogenetic 
glycoprotein (BMP) . A number of researchers have done 
animal experiments and clinical work using demineralized 
bone matrix to elicit osteogenesis (Hellonig et al. 1981; 
Hulliken and Glowacki, 1980; Kaban and Glowacki, 1981; 
Glowacki et al. 1981). 
There are a number of reasons why the batch of agent 
used in this study was not as potent as the agent prepared 
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at Sgulbb. For one thing, the potency of the agent 
extracted will vary with the individual animal it is 
extracted from. In other words, the ribs of one calf may 
provide a more potent batch than the ribs from some other 
calf. The extract from one of our trial batches seemed to 
be more potent than the extract used for the main part of 
this study (Tables 2 and 3). A second possible reason may 
be that we were not able to adequately duplicate the precise 
techniques and equipment used at Squibb Laboratories. The 
workers at Squibb Laboratories, where the agent was first 
developed, may have perfected a certain expertise in 
handling the substance, and they may have used equipment 
more suitable for working with it. In the case of the 
current investigation, the meat grinder from the Iowa State 
Meat Laboratory that was used to grind the bone, may have 
overheated the bone. The third possible reason may be 
because of the broad specifications of the patent procedure. 
In many places the patented procedure was not specific, it 
offered widely varying ranges in the time period certain 
steps should be done. For instance, it specified that the 
ground bone should be digested in the acid pepsin bath for 4 
hours to US hours. It did not specify an optimal time 
within that range. So, we selected a time period closer to 
the longer limit to give the enzyme more time to release the 
activation agent. 
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RECOMMENDATIONS AND CONSIDERATIONS FOR FURTHER RESEARCH 
It is unfortunate that previous workers discontinued 
research on this periosteal activation agent in the 1960s. 
It seems that a substance that has such an intense and 
immediate effect on the periosteum would be worthy of 
research to determine what it is, how it works, and what its 
potential applications may be. At the time they stopped 
research on the substance, they were pursuing the 
possibility that the active agent is a glycoprotein. 
Because of a lack of further research on its chemical 
structure, to the best of our knowledge, not even its 
approximate molecular weight is known (R. C. Millonig, The 
Squibb Institute for Medical Research, Princeton, N. J. 
08540, personal communcation). 
Research should be conducted to establish the chemical 
composition of the active agent or agents in this extract, 
and to prepare samples of the pure active agent or agents. 
The extract that we are now using is most likely a 
collection of many hundreds or perhaps thousands of 
different compounds. If only the active agent or agents 
could be separated from this extract, then we nay have a 
substance that is hundreds or thousands of times more potent 
than the raw extract used in this study. By removing the 
unneccessary compounds from this extract, we may be removing 
some substances that may cause adverse side effects or 
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adverse long-term effects in some animals. Also by 
isolating the precise agents responsible for the activation 
response, we will be providing the research community with a 
well characterized substance that may be used for basic 
research on bone. The best way to determine if PAA will 
stimulate activation of the endosteum, may be by using just 
the pure activating agents. Such research on the pure 
activation agents may lead to efficacious applications in 
human or veterinary medicine. Once the pure agents have 
been identified, it may be possible to mass produce them by 
using recombinant DNA techniques. 
The biochemical process of identifying the activation 
agent or agents may start by using molecular sieve 
techniques to identify the approximate molecular weights of 
the agents. Electrophoresis may then be used to isolate the 
specific substance or substances. Recently Hanamura et al. 
(1980) have been able to obtain values for the approximate 
molecular weights of BMP by molecular sieve techniques 
utilizing thin-channel diafiltration and gel filtration and 
gel electrophoresis. Similar techniques can be applied to 
PAA. However, if the action of PAA is due to the influence 
of two or more chemical species, isolating those particular 
species may be difficult. A preliminary molecular sieve 
study that we conducted gave an indication that the 
molecular weight of the active agent or agents in PAA is 
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greater than 1000 Daltons. 
In order to use PAA or its agents in humans, some basic 
conditions will have to be satisfied first. First, it must 
be shown that it is relatively safe to use. Something that 
stimulates such a rapid growth of bone may be suspected of 
being carcinogenic or causing ectopic bone formation* 
Though no cancer or ectopic bone formation was observed in 
any of the animals that we used in this study for time 
period up to 56 days, or in any of the rats that Tornberg 
and Bassett (1977) used (they observed them for up to 42 
days after application), that still does not prove that PAA 
will not cause cancer or ectopic bone formation. It may 
cause cancer after a longer delay. Some carcinogens take 
about 20 years to cause cancers in humans. It may cause 
cancer in other species of animals that have not been 
examined, or it may cause cancers at a frequency so low that 
it has not been detected yet. Second, it will need to be 
shown that it does work in humans. To the best of my 
knowledge, no human research has ever been done with this 
particular extract. 
The ability of PAA to activate the resting periosteum 
as demonstrated by Tornberg and Bassett (1977) and its 
ability to enhance periosteal callus formation as is 
demonstrated in this study may have a number of orthopedic 
applications. It may be used to stimulate bone growth from 
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the periosteum to encourage reattachment of broken tendons 
or ligaments or attachment of synthetic ligaments. It may 
be used to encourage periosteal attachment of artificial 
joints* Such applications would be based on new periosteal 
growth into the pores of a fabric or into the ridges or 
pores of an orthopedic prosthesis that attaches to the 
outside of the bone rather than inside the medullary canal. 
Before these ideas can be applied, it will be necessary to 
examine the response of such periosteal new bone to specific 
biocompatible porous materials. 
Periosteal activation may be useful anywhere it is 
needed to stimulate growth in the periosteum. An 
endoprosthesis has been developed as an artificial hip 
implant that is designed with a sleeve that fits over the 
outside of the femoral shaft. On the inside of the sleeve 
there is an array of ridges. The endoprosthesis is attached 
to the bone by periosteal bone growth into the indentations 
of the grooves. This implant design has been shown to be 
effective in human applications (Plenk et al. 1978), thus 
showing that in some cases, periosteal new bone can provide 
a permanent bond to a grooved material. A periosteal 
activation agent may be extremely useful in accelerating 
bone ingrowth and interlocking into such a prosthesis. 
One scenario for efficacious application of PAA 
involves using the skeleton as a scaffold to attach 
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prostheses and monitoring devices. It may be possible to do 
this by affixing a biocompatible porous material to the 
outside of the implantable device. The pores should be of 
suitable size (over 100 //m in diameter) to permit bone 
Ingrowth and may be impregnated with a purified PAA. The 
periosteum of the bone where this device is to be attached 
could be stimulated with PAA, and the porous Interface of 
the device would be attached to it. In a matter of weeks, 
the clamping Instrument used could be removed and the device 
would stay attached to the skeleton by the mechanical 
interlocking of the bone ingrowth. 
Even if it is not feasible to use PAA in human 
applications, it may be useful in veterinary applications. 
It may be used to help attach, via porous interfaces, 
artificial joints in companion animals and in certain 
valuable breeding animals. Certain breeds of large bulls 
often become lame when their crucial ligaments fail under 
the forces of their weight. A periosteal activation agent 
may he used to attach synthetic replacement ligaments to the 
periosteum of their long bones. At the site of attachment 
with the bone, these materials would present a woven network 
with spaces large enough to permit bone ingrowth. It may be 
specific enough to encourage bone Ingrowth at the site of 
periosteal attachment without mineralizing the rest of the 
ligament. 
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Further research should be done to investigate the 
effects that PAA nay have on the endosteum. The isolated 
rabbit results from this study suggest that PAA may 
stimulate the cells of the endosteum. A way should be found 
to apply PAA to the endosteum with a minimum of assault to 
the endosteum. 
Further research should also be conducted on more 
efficient ways to apply PAA. Since it seems to act only on 
the cells of the cambium layer of the periosteum (or 
possibly on the cells of the endosteum) , ways should be 
found to target PAA precisely to the sites of the periosteum 
where new bone growth is desired. It would have been 
desirable in this study to use an X-ray viewer to observe 
more precisely where the PAA was being applied. Also, 
experiments could be performed with PAA embedded within the 
pores of a material. For example, if it is desired to 
encourage periosteal bone ingrowth into a loose nylon mesh, 
the PAA would be incorporated into a resorbable gelatin held 
within the pores of the mesh. Then as the bone grew into 
the pores of the mesh, it would be constantly exposed to 
more PAA. 
PAA, or its purified activation agents, may have 
research applications. It may be used to attach implanted 
instruments via porous or grooved interfaces to the 
periosteum in various animal models. It may be used in 
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basic research on the biology and biochemistry of bone 
growth and bone repair. The findings from such research may 
lead to applications that can not be foreseen today. 
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APPENDIX A 
Statistics of Radiation Counting 
Any radiation rate meter will show fluctuations in the 
readings from any source known to be constant. The only way 
to find the true rate of disintegration for a radiation 
source is to count all disintegrations until the source has 
decayed, and then average the number of counts at that time. 
Since this is usually impractical, an estimate of the true 
radiation rate can be made measuring the rate for a sample 
period of time. 
In a truly random process, the probability that exactly 
N events will occur in time t is given by: 
Pn = (Rt)Ne-Rt/N! 
where R = true mean rate of occurrence 
N! = N factorial = 1 X 2 X 3 ... N 
The above equation is an expression of the Poisson 
distribution, a statistical measure of the uncertainty in N 
is the standard deviation, <7 =^ir. In any reasonable 
counting situation, we may assume that t is known precisely, 
so that fluctuations in R = N/t are due entirely to 
fluctuations in N. Then; 
S = yjv/t 
A measure of N and t determines a value of R, which is only 
an estimate of the true value R. Thus, S is only an 
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estimate, but usually a sufficiently good one of p. 
It is sometimes convenient to express standard 
deviation as a fraction of the quantity being measured. The 
coefficient of variation, V, is: 
Vn = ^ N/N = ^/\[^ 
The coefficient of variation of the rate will have the same 
value: 
Vr = S/R = (^/t)/(N/t) = T/yJv 
When taking radiation measurements it is almost always 
necessary to take into account background counts. The count 
rate due to the sample will be: 
Rs = Rt - Rb 
where the small letters refer to sample, sample plus 
background, and background, respectively. 
The standard deviation of a sum or difference is given 
by : 
Ss = ^ St2 + Sb2 
thus, Ss =^(Nt/tt2) + (Nb/tbZ) 
= Y(Rt/tt) + (Rb/Tb) where tt and tb 
are the counting times with and without the sample. The 
corresponding coefficient of variation is: 
Vs = Ss/Rs = Ss/(Rt-Rb) 
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Example 
For the segments of the femurs from rabbit V of the 
empty defect series, day 7, three five minute counts were 
taken of each segment. For the proximal segments, the 
counts were: 
active segment : 4275 control segment : 3870 
4155 3920 
4198 3770 
total 12,628 11,560 
average = Ht 4,209.3 
3,853.3 The background radiation was 899 counts for each 5 
minute count. Subtracting background from each of the 5 
minute counts we have: 
active segment : 3376 control segment : 2971 
3256 3021 
3299 2871 
total 9,931 8,863 
average = Rt 3,310 2,954 
The activation ratios for the proximal segment is then, 
9,931/8,863 = 1 .12 
The standard deviation of each segment for 5 minute 
counts is then (5 minutes is being treated as one unit of 
time,so,tt = tb = 1) : 
For active segments For control segments 
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St = ^4,209.3 St = ^3,853.3 
Sb = ^099 Sb = ^099 
Ss = ^Stz + Sb2 Ss = ^St2 + Sb2 
= ^ 4,209.3 + 899 = 
= 71.47 = 68.94 
The coefficient of variation for 5 minute counts are 
For the active segment For the control segment 
Vs = Ss/Rs = 71.47/3310 Vs = 68.94/2954 
= 0.02159 = 0.02334 
= 2.16% = 2.33% 
The standard deviation of the mean, Ss is: 
Ss = Ss/\/n 
where n is the number of samples measured 
For the active segment For the control segment 
Ss = 71.47/y/3 Ss = 68.94/^ 
= 41.26 = 39.00 
We have developed two standard deviations, the standard 
deviation of the 5 minute count time Ss, and the standard 
deviation of the means of the 5 minute count times Ss. 
There is a probability of 0.683 that any single measurement 
of the rate will be within of the true value (where a is 
the true standard deviation). Similarly, there is a 
probability of 0.683 that any mean value calculated will be 
within ±a of the true mean value. The standard deviations 
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we measure, Ss and Ss , are estimates of the true standard 
deviations, a, and . The coefficient of variation, V, 
expresses the standard deviation as a function of the 
quantity being measured. For most of the samples counted, 
the coefficient of variation for the total count time was 
less than 5% for individual segments and less than 2.5% for 
the total femoral counts where the counts from each of the 
segments from the same femur were summed. 
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APPENDIX B 
Absorption of Gamma Radiation by the Sample 
The radioactive samples were counted inside a deep well 
counter. This is a type of counter where the crystal 
detector is a cylinder with a cylindrical hole in the 
center. The sample to be counted is placed in the hole in 
the detector. For the Picker^counter used, the crystal 
size was 7.62 cm (3 inches) in diameter and 7.62 cm high. 
The well in the center of the crystal was 2.8575 cm (1.125 
inches) in diameter and 5.08 cm (2 inches) high. The 
samples were placed in test tubes containing 2 ml of neutral 
buffered formalin. The test tubes with the samples were 
mechanically lowered into the deep well counter. 
If we take a look at the geometry of the counting 
situation, the outer surface of the bone is closer to a 
detector surface then the endosteal or inner surface of the 
bone. A gamma ray emitted from the inside surface of the 
femur may travel through the bone before it can be 
detected. What is the probability that such a gamma 
emission will be absorbed by the bone? The geometry of the 
counting situation is illustrated in Figure 36. 
The standard formula for absorption of gamma radiation 
is: 
I = lo X e-Pl" 
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a = air and glass 
e = endosteal surface 
f = neutral buffered 
formalin 
p = periosteal surface 
76 mm ^ 
(R) 
FIGURE 36. Counting geometry for sample in Picker deep well 
counter 
where I = intensity of gamma radiation at a given distance 
lo = intensity of gamma radiation at surface o 
p = density of the material the gamma rays pass 
through 
1 = length of the distance the gamma rays pass 
through 
u = mass absorption coefficient (cm^/g) 
A gamma ray that originates in the endosteal surface of 
the bone and heads directly to the closest detector surface, 
will have to travel through a given length of bone, 1, 
before it reaches the periosteal surface. Figure 37. 
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e = endosteal surface 
p = periosteal surface 
1 = width of cortex of femur, 
usually 0.8 mm to 1.2 mm 
FIGURE 37. Transverse cross section of a femur being 
counted in a deep well detector 
The cortical thickness of the rabbit femurs, 1, varied 
from 0«8 to 1.5 mm with an average of about 1.2 mm. The 
density of cortical bone is about 1.6 gm/cn^ (Carter and 
Spengle, 1978). At the energy of strontiuni-85 decay, 0.510 
HeV, the mass absorption coefficient varies from 0.9 cmz/g 
to 1.1 cm2/g for a wide range of materials (water, carbon, 
copper, iron, and air). If the mass absorption coefficient 
is assumed to be 1.0 cm^/g, and the density is 1.8 g/cm3, 
and the length is 0.12 cm, then, 
I = lo X e~* * «0 8 >« 0, 1 2 > 
I = 0.806IO 
If the gamma ray travels through 0.2 cm of bone, then. 
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I = 0.7001O. 
Although this is not a. rigorous analysis of the seli.' 
absorption problem « it does show that strontium-^85 from 
endosteal new bone is less likely to be detected than the 
strontium in the periosteal new bone. Thus, about 80% of 
the gamma radiation from strontium-85 will pass through 1.2 
mm of cortical bone without being absorbed, and about 70% of 
such gamma radiation will pass through 2 mm of cortical 
bone • 
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APPENDIX C 
Correlation Statistics 
Correlation is a measure of the linear relation that 
exists between two variables. The sample linear correlation 
coefficient, r, also called the simple correlation, the 
total correlation and the product-moment correlation, is 
used for descriptive purposes and is defined by: 
£(x-x ) (Y-y) / (n - l )  
V2(x-x)y(n-i) ^z(Y-y)7(n-l) 
_  £ fx -x ) (Y-y)  
^r( X - i )'E( Y - y ) '  
Where X, and Y are variables 
X, and y are mean values of X and Y respectively 
and Z signifies summation of all values of X and Y functions. 
The correlation coefficient, r, is an estimate of the 
corresponding population correlation coefficient P. The 
correlation coefficient will always have a value between -1 
and +1 « Values near +1 or -1 indicate a high degree of 
correlation while values near zero indicate a low degree of 
correlation. Negative values indicate that the two 
variables tend to vary in opposite directions. In other 
words, as X increases, Y tends to decrease. 
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The coefficient of determination is r^, the square of 
the correlation coefficient. In regression analysis, r^ is 
the proportion of a total sum of squares that is 
attributable to another source of variation, the independent 
variable. In other words, rZ gives the variation in a 
dependent variable that is explained by the independent 
variable. 
Confidence limits on p can be found by using the charts 
prepared by David (1938). 
To correlate the image analysis data from the 
midsegment of the empty defect series with the strontium 
tracer data from the same segments, set up the table as 
shown in Table 23. 
Then calculate 
Example 
ZX = 11.067 
Ex 2 = 21.777 
EY = 9.585 
EYZ = 14.808 
EXÏ = 16.925 
Use the functional formula for r, 
r 
ZXY-Z^ 
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TABLE 23, X are the ratios from the image analysis data and 
Y are the activation ratios from the strontium 
tracer 
Rabbit 
ED1I 0.478 0.895 
ED3III 1 .284 1 .142 
ED5III 2.609 1 .708 
ED71 0.656 0.793 
ED7V 1 .558 1.375 
ED10IV 2.55 1 .324 
EDI 41 1.932 2.348 
r = 1.771U19/ (4.200) (1 .683) 
r = 0.660 
rz = 0.4355 
From the chart of Confidence Belts for the Correlation 
Coefficient, p, where P = .95 and P = .99 (David, 1938), we 
find that with n = 7 and r = 0.660, that the 95% confidence 
interval is from -0.17 to +0.92, which means that there is 
at least a 95X probability that the actual correlation is 
between -0.17 and +0.92. The probability correlation 
coeficient is a non-dimensional value. 
